{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.10.14","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[{"sourceId":85725,"databundleVersionId":9691631,"sourceType":"competition"}],"dockerImageVersionId":30775,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"# This Python 3 environment comes with many helpful analytics libraries installed\n# It is defined by the kaggle/python Docker image: https://github.com/kaggle/docker-python\n# For example, here's several helpful packages to load\n\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I/O (e.g. pd.read_csv)\n\n# Input data files are available in the read-only \"../input/\" directory\n# For example, running this (by clicking run or pressing Shift+Enter) will list all files under the input directory\n\nimport os\nfor dirname, _, filenames in os.walk('/kaggle/input'):\n    for filename in filenames:\n        print(os.path.join(dirname, filename))\n\n# You can write up to 20GB to the current directory (/kaggle/working/) that gets preserved as output when you create a version using \"Save & Run All\" \n# You can also write temporary files to /kaggle/temp/, but they won't be saved outside of the current session","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","execution":{"iopub.status.busy":"2024-09-27T02:00:16.375029Z","iopub.execute_input":"2024-09-27T02:00:16.375494Z","iopub.status.idle":"2024-09-27T02:00:17.389334Z","shell.execute_reply.started":"2024-09-27T02:00:16.375451Z","shell.execute_reply":"2024-09-27T02:00:17.388005Z"},"trusted":true},"execution_count":1,"outputs":[{"name":"stdout","text":"/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/sample_submission.csv\n/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/train.csv\n/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/test.csv\n","output_type":"stream"}]},{"cell_type":"markdown","source":"# Preprocessing","metadata":{}},{"cell_type":"code","source":"import pandas as pd\ndata = pd.read_csv('/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/train.csv')\ndata.head()\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:00:17.391860Z","iopub.execute_input":"2024-09-27T02:00:17.392895Z","iopub.status.idle":"2024-09-27T02:00:23.179243Z","shell.execute_reply.started":"2024-09-27T02:00:17.392847Z","shell.execute_reply":"2024-09-27T02:00:23.177817Z"},"trusted":true},"execution_count":2,"outputs":[{"name":"stdout","text":"Done\n","output_type":"stream"}]},{"cell_type":"code","source":"drop_cols = ['TargetID', 'DRUGID',\n       'PUBCHCID', 'UNIPROID',\n       'TARGNAME', 'SYNONYMS', 'FUNCTION', 'BIOCLASS',\n       'Accession Number'] # 'ID' - less acc/f1\n\ndata.drop(drop_cols, inplace=True, axis=1)\ndata.head(5)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:00:23.180636Z","iopub.execute_input":"2024-09-27T02:00:23.181073Z","iopub.status.idle":"2024-09-27T02:00:23.218822Z","shell.execute_reply.started":"2024-09-27T02:00:23.181031Z","shell.execute_reply":"2024-09-27T02:00:23.217715Z"},"trusted":true},"execution_count":3,"outputs":[{"name":"stdout","text":"Done\n","output_type":"stream"}]},{"cell_type":"code","source":"from sklearn.model_selection import train_test_split\nX_train, X_val, y_train, y_val = train_test_split(data.drop('Target_Status', axis=1),\n                                                  data['Target_Status'], random_state=42,\n                                                  stratify=data['Target_Status'], shuffle=True)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:00:23.221512Z","iopub.execute_input":"2024-09-27T02:00:23.221963Z","iopub.status.idle":"2024-09-27T02:00:24.119263Z","shell.execute_reply.started":"2024-09-27T02:00:23.221914Z","shell.execute_reply":"2024-09-27T02:00:24.118126Z"},"trusted":true},"execution_count":4,"outputs":[{"name":"stdout","text":"Done\n","output_type":"stream"}]},{"cell_type":"code","source":"le_cols = ['DRUGTYPE', 'Drug_high_status', 'DRUGNAME',\n       'Disease_of_highest_status', 'Drug_Status', 'GENENAME', 'SEQUENCE',\n       'Disease']","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:00:24.120879Z","iopub.execute_input":"2024-09-27T02:00:24.121644Z","iopub.status.idle":"2024-09-27T02:00:24.127082Z","shell.execute_reply.started":"2024-09-27T02:00:24.121587Z","shell.execute_reply":"2024-09-27T02:00:24.125913Z"},"trusted":true},"execution_count":5,"outputs":[]},{"cell_type":"code","source":"from sklearn.preprocessing import LabelEncoder\nfor i in le_cols:\n    le = LabelEncoder()\n    X_train[i] = le.fit_transform(X_train[i])\n    X_val[i] = X_val[i].apply(lambda x: le.transform([x])[0] if x in le.classes_ else -1 if pd.notna(x) else -1)\n# X_test[col] = X_test[col].apply(lambda x: label_encoder.transform([x])[0] if x in label_encoder.classes_ else -1 if pd.notna(x) else -1)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:00:24.128527Z","iopub.execute_input":"2024-09-27T02:00:24.128927Z","iopub.status.idle":"2024-09-27T02:02:52.893441Z","shell.execute_reply.started":"2024-09-27T02:00:24.128890Z","shell.execute_reply":"2024-09-27T02:02:52.892070Z"},"trusted":true},"execution_count":6,"outputs":[{"name":"stdout","text":"Done\n","output_type":"stream"}]},{"cell_type":"code","source":"le = LabelEncoder()\ny_train = le.fit_transform(y_train)\n# y_val = le.transform(y_val)\ny_val = y_val.apply(lambda x: le.transform([x])[0] if x in le.classes_ else -1 if pd.notna(x) else -1)\nprint(le.classes_)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:02:52.896198Z","iopub.execute_input":"2024-09-27T02:02:52.896604Z","iopub.status.idle":"2024-09-27T02:02:55.661181Z","shell.execute_reply.started":"2024-09-27T02:02:52.896566Z","shell.execute_reply":"2024-09-27T02:02:55.659956Z"},"trusted":true},"execution_count":7,"outputs":[{"name":"stdout","text":"['Application submitted' 'Approved' 'Approved (orphan drug)'\n 'BLA submitted' 'Clinical trial' 'Discontinued in Phase 1'\n 'Discontinued in Phase 1/2' 'Discontinued in Phase 2'\n 'Discontinued in Phase 2/3' 'Discontinued in Phase 2b'\n 'Discontinued in Phase 3' 'Discontinued in Phase 4'\n 'Discontinued in Preregistration' 'IND submitted' 'Investigative'\n 'Patented' 'Phase 0' 'Phase 1' 'Phase 1/2' 'Phase 1/2a' 'Phase 1b'\n 'Phase 1b/2a' 'Phase 2' 'Phase 2/3' 'Phase 2a' 'Phase 2b' 'Phase 3'\n 'Phase 4' 'Preclinical' 'Preregistration' 'Registered' 'Terminated'\n 'Withdrawn from market']\nDone\n","output_type":"stream"}]},{"cell_type":"code","source":"X_train.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:02:55.662388Z","iopub.execute_input":"2024-09-27T02:02:55.662714Z","iopub.status.idle":"2024-09-27T02:02:55.682926Z","shell.execute_reply.started":"2024-09-27T02:02:55.662681Z","shell.execute_reply":"2024-09-27T02:02:55.681705Z"},"trusted":true},"execution_count":8,"outputs":[{"execution_count":8,"output_type":"execute_result","data":{"text/plain":"           ID  DRUGTYPE  Drug_high_status  DRUGNAME  \\\n88082  131977         4                 0       808   \n36973  189122         4                 0      2069   \n76161  112276         4                 0      1071   \n5088    78657         4                 0      2322   \n76923   39756         4                 0       375   \n\n       Disease_of_highest_status  Drug_Status  GENENAME  SEQUENCE  Disease  \n88082                        487            1       549       593      271  \n36973                        434           17       250       452      260  \n76161                        607           12         1       157      515  \n5088                         590            1       249       669      155  \n76923                        573            1       200       109      384  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>GENENAME</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>88082</th>\n      <td>131977</td>\n      <td>4</td>\n      <td>0</td>\n      <td>808</td>\n      <td>487</td>\n      <td>1</td>\n      <td>549</td>\n      <td>593</td>\n      <td>271</td>\n    </tr>\n    <tr>\n      <th>36973</th>\n      <td>189122</td>\n      <td>4</td>\n      <td>0</td>\n      <td>2069</td>\n      <td>434</td>\n      <td>17</td>\n      <td>250</td>\n      <td>452</td>\n      <td>260</td>\n    </tr>\n    <tr>\n      <th>76161</th>\n      <td>112276</td>\n      <td>4</td>\n      <td>0</td>\n      <td>1071</td>\n      <td>607</td>\n      <td>12</td>\n      <td>1</td>\n      <td>157</td>\n      <td>515</td>\n    </tr>\n    <tr>\n      <th>5088</th>\n      <td>78657</td>\n      <td>4</td>\n      <td>0</td>\n      <td>2322</td>\n      <td>590</td>\n      <td>1</td>\n      <td>249</td>\n      <td>669</td>\n      <td>155</td>\n    </tr>\n    <tr>\n      <th>76923</th>\n      <td>39756</td>\n      <td>4</td>\n      <td>0</td>\n      <td>375</td>\n      <td>573</td>\n      <td>1</td>\n      <td>200</td>\n      <td>109</td>\n      <td>384</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"y_train[:5]","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:02:55.684332Z","iopub.execute_input":"2024-09-27T02:02:55.684687Z","iopub.status.idle":"2024-09-27T02:02:55.692056Z","shell.execute_reply.started":"2024-09-27T02:02:55.684650Z","shell.execute_reply":"2024-09-27T02:02:55.690927Z"},"trusted":true},"execution_count":9,"outputs":[{"execution_count":9,"output_type":"execute_result","data":{"text/plain":"array([ 1,  1, 17,  7, 14])"},"metadata":{}}]},{"cell_type":"markdown","source":"# Trying all baselines - XGB works the best followed by CatBoost","metadata":{}},{"cell_type":"code","source":"import pandas as pd\nfrom sklearn.model_selection import train_test_split\nfrom sklearn.metrics import accuracy_score, f1_score\nfrom sklearn.linear_model import LogisticRegression\nfrom sklearn.ensemble import RandomForestClassifier, GradientBoostingClassifier\nfrom sklearn.svm import SVC\nfrom sklearn.tree import DecisionTreeClassifier\nfrom sklearn.neighbors import KNeighborsClassifier\nfrom sklearn.naive_bayes import GaussianNB\nimport xgboost as xgb\nimport lightgbm as lgb\nfrom catboost import CatBoostClassifier\nfrom sklearn.ensemble import AdaBoostClassifier","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:02:57.781637Z","iopub.execute_input":"2024-09-27T02:02:57.782182Z","iopub.status.idle":"2024-09-27T02:02:57.788506Z","shell.execute_reply.started":"2024-09-27T02:02:57.782143Z","shell.execute_reply":"2024-09-27T02:02:57.787325Z"},"trusted":true},"execution_count":11,"outputs":[]},{"cell_type":"code","source":"models = {\n    \"Logistic Regression\": LogisticRegression(max_iter=1000),\n    \"Random Forest\": RandomForestClassifier(),\n    \"XGBoost\": xgb.XGBClassifier(use_label_encoder=False, eval_metric='mlogloss'),\n    \"LightGBM\": lgb.LGBMClassifier(verbosity=0),\n    \"CatBoost\": CatBoostClassifier(silent=True),\n#     \"Support Vector Classifier\": SVC(),\n#     \"Decision Tree\": DecisionTreeClassifier(),\n#     \"K-Nearest Neighbors\": KNeighborsClassifier(),\n    \"Gaussian Naive Bayes\": GaussianNB(),\n#     \"Gradient Boosting\": GradientBoostingClassifier(),\n    \"AdaBoost\": AdaBoostClassifier(),  \n}\n\n# Initialize an empty list to store results\nresults_list = []","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:02:57.789744Z","iopub.execute_input":"2024-09-27T02:02:57.790096Z","iopub.status.idle":"2024-09-27T02:02:57.804569Z","shell.execute_reply.started":"2024-09-27T02:02:57.790060Z","shell.execute_reply":"2024-09-27T02:02:57.803549Z"},"trusted":true},"execution_count":12,"outputs":[]},{"cell_type":"code","source":"# Train and evaluate each model\nfor model_name, model in models.items():\n    # Train the model\n    model.fit(X_train, y_train)\n    \n    # Predict on validation set\n    y_pred = model.predict(X_val)\n    \n    # Calculate evaluation metrics\n    accuracy = accuracy_score(y_val, y_pred)\n    f1 = f1_score(y_val, y_pred, average='weighted')  # Use 'weighted' for multi-class classification\n    \n    # Append results to the list\n    results_list.append({\"Model\": model_name, \"Accuracy\": accuracy, \"F1 Score\": f1})\n    print('-'*25)\n    print(model_name)\n    print('-'*25)\n    print('Accuracy : ', accuracy)\n    print('F1 Score : ', f1)\n    print('*'*50)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:02:57.807962Z","iopub.execute_input":"2024-09-27T02:02:57.808843Z","iopub.status.idle":"2024-09-27T02:14:38.517758Z","shell.execute_reply.started":"2024-09-27T02:02:57.808778Z","shell.execute_reply":"2024-09-27T02:14:38.516544Z"},"trusted":true},"execution_count":13,"outputs":[{"name":"stderr","text":"/opt/conda/lib/python3.10/site-packages/sklearn/linear_model/_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\nSTOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n\nIncrease the number of iterations (max_iter) or scale the data as shown in:\n    https://scikit-learn.org/stable/modules/preprocessing.html\nPlease also refer to the documentation for alternative solver options:\n    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n  n_iter_i = _check_optimize_result(\n","output_type":"stream"},{"name":"stdout","text":"-------------------------\nLogistic Regression\n-------------------------\nAccuracy :  0.23680923205044316\nF1 Score :  0.15387254746280993\n**************************************************\n-------------------------\nRandom Forest\n-------------------------\nAccuracy :  0.8648206531437749\nF1 Score :  0.8641705222436125\n**************************************************\n-------------------------\nXGBoost\n-------------------------\nAccuracy :  0.9460769734102671\nF1 Score :  0.9460924605933527\n**************************************************\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n-------------------------\nLightGBM\n-------------------------\nAccuracy :  0.2623877223246684\nF1 Score :  0.2675073508905537\n**************************************************\n-------------------------\nCatBoost\n-------------------------\nAccuracy :  0.9077389804294806\nF1 Score :  0.9077916471263655\n**************************************************\n-------------------------\nGaussian Naive Bayes\n-------------------------\nAccuracy :  0.24448277913271071\nF1 Score :  0.15892716124535702\n**************************************************\n-------------------------\nAdaBoost\n-------------------------\nAccuracy :  0.23282374635655226\nF1 Score :  0.13194107618103204\n**************************************************\n","output_type":"stream"}]},{"cell_type":"code","source":"# Create a DataFrame from the results list\nresults_df = pd.DataFrame(results_list)\n\n# Print the results DataFrame\nprint(results_df)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:14:38.823817Z","iopub.execute_input":"2024-09-27T02:14:38.824409Z","iopub.status.idle":"2024-09-27T02:14:38.837514Z","shell.execute_reply.started":"2024-09-27T02:14:38.824362Z","shell.execute_reply":"2024-09-27T02:14:38.836253Z"},"trusted":true},"execution_count":15,"outputs":[{"name":"stdout","text":"                  Model  Accuracy  F1 Score\n0   Logistic Regression  0.236809  0.153873\n1         Random Forest  0.864821  0.864171\n2               XGBoost  0.946077  0.946092\n3              LightGBM  0.262388  0.267507\n4              CatBoost  0.907739  0.907792\n5  Gaussian Naive Bayes  0.244483  0.158927\n6              AdaBoost  0.232824  0.131941\n","output_type":"stream"}]},{"cell_type":"markdown","source":"----","metadata":{}},{"cell_type":"markdown","source":"# Optuna for XGB","metadata":{}},{"cell_type":"code","source":"# import optuna\n# import xgboost as xgb\n# from sklearn.metrics import accuracy_score\n\n# # Define the objective function\n# def objective(trial):\n#     # Suggest hyperparameters\n#     param = {\n#         'objective': 'multi:softmax',  # Use 'multi:softmax' for multi-class classification\n#         'eval_metric': 'mlogloss',      # Multiclass log loss\n#         'num_class': 33,                  # Set this to the number of classes in your target\n#         'max_depth': trial.suggest_int('max_depth', 8, 20),\n#         'learning_rate': trial.suggest_float('learning_rate', 1e-5, 1.0),\n#         'n_estimators': trial.suggest_int('n_estimators', 200, 500),\n#         'subsample': trial.suggest_float('subsample', 0.5, 1.0),\n#         'colsample_bytree': trial.suggest_float('colsample_bytree', 0.1, 1.0),\n#         'gamma': trial.suggest_float('gamma', 0, 1),\n#         'min_child_weight': trial.suggest_int('min_child_weight', 1, 5),\n#         'use_label_encoder': False,\n#         'random_state': 42,\n# #         'n_jobs': -1\n#     }\n\n#     # Train the model\n#     model = xgb.XGBClassifier(**param)\n#     model.fit(X_train, y_train)\n\n#     # Predict on the validation set\n#     y_pred = model.predict(X_val)\n    \n#     # Return the accuracy\n#     return accuracy_score(y_val, y_pred)\n\n\n# # Create a study object and optimize the objective function\n# study = optuna.create_study(direction='maximize')\n# study.optimize(objective, n_trials=600, n_jobs=-1, show_progress_bar=True)\n\n# # Print the best parameters and best score\n# print(\"Best trial:\")\n# trial = study.best_trial\n\n# print(\"  Value: {}\".format(trial.value))\n# print(\"  Params:\")\n# for key, value in trial.params.items():\n#     print(\"    {}: {}\".format(key, value))","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:19:03.205574Z","iopub.execute_input":"2024-09-27T02:19:03.206751Z","iopub.status.idle":"2024-09-27T02:19:03.212717Z","shell.execute_reply.started":"2024-09-27T02:19:03.206702Z","shell.execute_reply":"2024-09-27T02:19:03.211504Z"},"trusted":true},"execution_count":16,"outputs":[]},{"cell_type":"markdown","source":"Best I found\n\n[I 2024-09-26 16:35:57,728] Trial 18 finished with value: 0.9610076735470823 and parameters: {'max_depth': 10, 'learning_rate': 0.5725149095634108, 'n_estimators': 282, 'subsample': 0.8986564310339598, 'colsample_bytree': 0.9987859907146507, 'gamma': 0.2985150092707789, 'min_child_weight': 3}. Best is trial 18 with value: 0.9610076735470823.\n\n[I 2024-09-26 17:03:43,712] Trial 61 finished with value: 0.9629409315329248 and parameters: {'max_depth': 10, 'learning_rate': 0.30470042106011347, 'n_estimators': 271, 'subsample': 0.9751148225155233, 'colsample_bytree': 0.9783082452116838, 'gamma': 0.060583391663396303, 'min_child_weight': 2}. Best is trial 61 with value: 0.9629409315329248.\n\n[I 2024-09-26 17:26:35,640] Trial 90 finished with value: 0.9631193861162334 and parameters: {'max_depth': 10, 'learning_rate': 0.09887667319531757, 'n_estimators': 286, 'subsample': 0.8818473315577697, 'colsample_bytree': 0.7911835582470869, 'gamma': 0.5882283567417588, 'min_child_weight': 1}. Best is trial 90 with value: 0.9631193861162334.\n\n[I 2024-09-27 00:36:46,862] Trial 125 finished with value: 0.9646957349354589 and parameters: {'max_depth': 17, 'learning_rate': 0.0663028870385258, 'n_estimators': 409, 'subsample': 0.9629463287306949, 'colsample_bytree': 0.8300614936416831, 'gamma': 0.2857062337129327, 'min_child_weight': 3}. Best is trial 125 with value: 0.9646957349354589.\n\n[I 2024-09-27 02:30:03,154] Trial 159 finished with value: 0.9652013562548332 and parameters: {'max_depth': 18, 'learning_rate': 0.02554741000702669, 'n_estimators': 418, 'subsample': 0.9899632082718985, 'colsample_bytree': 0.8226626583591214, 'gamma': 0.9701683008405076, 'min_child_weight': 3}. Best is trial 159 with value: 0.9652013562548332.\n\n[I 2024-09-27 02:57:15,528] Trial 165 finished with value: 0.9654095532686932 and parameters: {'max_depth': 18, 'learning_rate': 0.026580724023369313, 'n_estimators': 435, 'subsample': 0.9907353184547363, 'colsample_bytree': 0.8160409175832265, 'gamma': 0.9512455197681707, 'min_child_weight': 3}. Best is trial 165 with value: 0.9654095532686932.","metadata":{}},{"cell_type":"code","source":"# params = study.best_params\nparams = {'max_depth': 17, 'learning_rate': 0.0663028870385258, 'n_estimators': 409,\n          'subsample': 0.9629463287306949, 'colsample_bytree': 0.8300614936416831,\n          'gamma': 0.2857062337129327, 'min_child_weight': 3}\nprint(params)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:19:31.729454Z","iopub.execute_input":"2024-09-27T02:19:31.729891Z","iopub.status.idle":"2024-09-27T02:19:31.737392Z","shell.execute_reply.started":"2024-09-27T02:19:31.729853Z","shell.execute_reply":"2024-09-27T02:19:31.736103Z"},"trusted":true},"execution_count":17,"outputs":[{"name":"stdout","text":"{'max_depth': 17, 'learning_rate': 0.0663028870385258, 'n_estimators': 409, 'subsample': 0.9629463287306949, 'colsample_bytree': 0.8300614936416831, 'gamma': 0.2857062337129327, 'min_child_weight': 3}\n","output_type":"stream"}]},{"cell_type":"code","source":"from sklearn.metrics import f1_score\nmodel = xgb.XGBClassifier(**params)\nmodel.fit(X_train, y_train)\n\ny_pred = model.predict(X_val)\nprint(f1_score(y_pred, y_val, average='weighted'))","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:19:49.628538Z","iopub.execute_input":"2024-09-27T02:19:49.629434Z","iopub.status.idle":"2024-09-27T02:22:56.001476Z","shell.execute_reply.started":"2024-09-27T02:19:49.629387Z","shell.execute_reply":"2024-09-27T02:22:55.999994Z"},"trusted":true},"execution_count":18,"outputs":[{"name":"stdout","text":"0.963977125903392\n","output_type":"stream"}]},{"cell_type":"code","source":"# import optuna.visualization as vis\n\n# fig_optimization_history = vis.plot_optimization_history(study)\n# fig_optimization_history.show()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:22:56.003633Z","iopub.execute_input":"2024-09-27T02:22:56.004022Z","iopub.status.idle":"2024-09-27T02:22:56.009120Z","shell.execute_reply.started":"2024-09-27T02:22:56.003981Z","shell.execute_reply":"2024-09-27T02:22:56.007912Z"},"trusted":true},"execution_count":19,"outputs":[]},{"cell_type":"markdown","source":"# Predictions on test set","metadata":{}},{"cell_type":"code","source":"test = pd.read_csv(\"/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/test.csv\")\ntest.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:25:05.439617Z","iopub.execute_input":"2024-09-27T02:25:05.440122Z","iopub.status.idle":"2024-09-27T02:25:07.853702Z","shell.execute_reply.started":"2024-09-27T02:25:05.440077Z","shell.execute_reply":"2024-09-27T02:25:07.852711Z"},"trusted":true},"execution_count":20,"outputs":[{"execution_count":20,"output_type":"execute_result","data":{"text/plain":"       ID TargetID  DRUGID              DRUGTYPE Drug_high_status  \\\n0    1076   T51487  D0HO2T  Small molecular drug          Phase 2   \n1  190816   T74312  D0Q4EQ  Small molecular drug    Investigative   \n2  180551   T40474  D0R0MW  Small molecular drug         Approved   \n3   51630   T67162  D0T2XU  Small molecular drug         Approved   \n4   50566   T67162  D0H7KF  Small molecular drug         Approved   \n\n       DRUGNAME  PUBCHCID        Disease_of_highest_status    Drug_Status  \\\n0       AZD7325  23581869                 Anxiety disorder        Phase 2   \n1  JNJ-38158471  16742063            Angiogenesis disorder  Investigative   \n2     Sunitinib   5329102  Gastrointestinal stromal tumour       Approved   \n3  Promethazine      4927                           Nausea       Approved   \n4    Quetiapine      5002               Alcohol dependence        Phase 3   \n\n      UNIPROID                            TARGNAME GENENAME  \\\n0  GBRA1_HUMAN   GABA(A) receptor alpha-1 (GABRA1)   GABRA1   \n1   FLT3_HUMAN  Fms-like tyrosine kinase 3 (FLT-3)     FLT3   \n2    MET_HUMAN          Proto-oncogene c-Met (MET)      MET   \n3   DRD2_HUMAN          Dopamine D2 receptor (D2R)     DRD2   \n4   DRD2_HUMAN          Dopamine D2 receptor (D2R)     DRD2   \n\n                                            SYNONYMS  \\\n0  Gamma-aminobutyric acid receptor subunit alpha...   \n1  Stem cell tyrosine kinase 1; STK1; STK-1; Rece...   \n2  Tyrosine-protein kinase Met; Scatter factor re...   \n3        Dopamine receptor 2; D(2) dopamine receptor   \n4        Dopamine receptor 2; D(2) dopamine receptor   \n\n                                            FUNCTION  \\\n0  Ligand-gated chloride channel which is a compo...   \n1  Tyrosine-protein kinase that acts as cell-surf...   \n2  Regulates many physiological processes includi...   \n3  Dopamine receptor whose activity is mediated b...   \n4  Dopamine receptor whose activity is mediated b...   \n\n                   BIOCLASS  \\\n0  Ligand-gated ion channel   \n1                    Kinase   \n2                    Kinase   \n3            GPCR rhodopsin   \n4            GPCR rhodopsin   \n\n                                            SEQUENCE  \\\n0  MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRIL...   \n1  MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSS...   \n2  MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNF...   \n3  MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...   \n4  MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...   \n\n                             Disease Accession Number  \n0                            Malaria           P14867  \n1  Malignant haematopoietic neoplasm           P36888  \n2                       Liver cancer           Q86W50  \n3                         Depression           P14416  \n4                           Lymphoma           P14416  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>TargetID</th>\n      <th>DRUGID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>PUBCHCID</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>UNIPROID</th>\n      <th>TARGNAME</th>\n      <th>GENENAME</th>\n      <th>SYNONYMS</th>\n      <th>FUNCTION</th>\n      <th>BIOCLASS</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n      <th>Accession Number</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>T51487</td>\n      <td>D0HO2T</td>\n      <td>Small molecular drug</td>\n      <td>Phase 2</td>\n      <td>AZD7325</td>\n      <td>23581869</td>\n      <td>Anxiety disorder</td>\n      <td>Phase 2</td>\n      <td>GBRA1_HUMAN</td>\n      <td>GABA(A) receptor alpha-1 (GABRA1)</td>\n      <td>GABRA1</td>\n      <td>Gamma-aminobutyric acid receptor subunit alpha...</td>\n      <td>Ligand-gated chloride channel which is a compo...</td>\n      <td>Ligand-gated ion channel</td>\n      <td>MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRIL...</td>\n      <td>Malaria</td>\n      <td>P14867</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>T74312</td>\n      <td>D0Q4EQ</td>\n      <td>Small molecular drug</td>\n      <td>Investigative</td>\n      <td>JNJ-38158471</td>\n      <td>16742063</td>\n      <td>Angiogenesis disorder</td>\n      <td>Investigative</td>\n      <td>FLT3_HUMAN</td>\n      <td>Fms-like tyrosine kinase 3 (FLT-3)</td>\n      <td>FLT3</td>\n      <td>Stem cell tyrosine kinase 1; STK1; STK-1; Rece...</td>\n      <td>Tyrosine-protein kinase that acts as cell-surf...</td>\n      <td>Kinase</td>\n      <td>MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSS...</td>\n      <td>Malignant haematopoietic neoplasm</td>\n      <td>P36888</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>T40474</td>\n      <td>D0R0MW</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Sunitinib</td>\n      <td>5329102</td>\n      <td>Gastrointestinal stromal tumour</td>\n      <td>Approved</td>\n      <td>MET_HUMAN</td>\n      <td>Proto-oncogene c-Met (MET)</td>\n      <td>MET</td>\n      <td>Tyrosine-protein kinase Met; Scatter factor re...</td>\n      <td>Regulates many physiological processes includi...</td>\n      <td>Kinase</td>\n      <td>MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNF...</td>\n      <td>Liver cancer</td>\n      <td>Q86W50</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>T67162</td>\n      <td>D0T2XU</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Promethazine</td>\n      <td>4927</td>\n      <td>Nausea</td>\n      <td>Approved</td>\n      <td>DRD2_HUMAN</td>\n      <td>Dopamine D2 receptor (D2R)</td>\n      <td>DRD2</td>\n      <td>Dopamine receptor 2; D(2) dopamine receptor</td>\n      <td>Dopamine receptor whose activity is mediated b...</td>\n      <td>GPCR rhodopsin</td>\n      <td>MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...</td>\n      <td>Depression</td>\n      <td>P14416</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>T67162</td>\n      <td>D0H7KF</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Quetiapine</td>\n      <td>5002</td>\n      <td>Alcohol dependence</td>\n      <td>Phase 3</td>\n      <td>DRD2_HUMAN</td>\n      <td>Dopamine D2 receptor (D2R)</td>\n      <td>DRD2</td>\n      <td>Dopamine receptor 2; D(2) dopamine receptor</td>\n      <td>Dopamine receptor whose activity is mediated b...</td>\n      <td>GPCR rhodopsin</td>\n      <td>MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...</td>\n      <td>Lymphoma</td>\n      <td>P14416</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"test.isna().sum()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:25:07.855699Z","iopub.execute_input":"2024-09-27T02:25:07.856193Z","iopub.status.idle":"2024-09-27T02:25:07.908524Z","shell.execute_reply.started":"2024-09-27T02:25:07.856153Z","shell.execute_reply":"2024-09-27T02:25:07.907392Z"},"trusted":true},"execution_count":21,"outputs":[{"execution_count":21,"output_type":"execute_result","data":{"text/plain":"ID                           0\nTargetID                     0\nDRUGID                       0\nDRUGTYPE                     0\nDrug_high_status             0\nDRUGNAME                     0\nPUBCHCID                     0\nDisease_of_highest_status    0\nDrug_Status                  0\nUNIPROID                     0\nTARGNAME                     0\nGENENAME                     0\nSYNONYMS                     0\nFUNCTION                     0\nBIOCLASS                     0\nSEQUENCE                     0\nDisease                      0\nAccession Number             0\ndtype: int64"},"metadata":{}}]},{"cell_type":"code","source":"test.drop(drop_cols, axis=1, inplace=True)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:25:07.910055Z","iopub.execute_input":"2024-09-27T02:25:07.910655Z","iopub.status.idle":"2024-09-27T02:25:07.924281Z","shell.execute_reply.started":"2024-09-27T02:25:07.910603Z","shell.execute_reply":"2024-09-27T02:25:07.923075Z"},"trusted":true},"execution_count":22,"outputs":[]},{"cell_type":"code","source":"test.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:25:10.318451Z","iopub.execute_input":"2024-09-27T02:25:10.319413Z","iopub.status.idle":"2024-09-27T02:25:10.336875Z","shell.execute_reply.started":"2024-09-27T02:25:10.319361Z","shell.execute_reply":"2024-09-27T02:25:10.335602Z"},"trusted":true},"execution_count":23,"outputs":[{"execution_count":23,"output_type":"execute_result","data":{"text/plain":"       ID              DRUGTYPE Drug_high_status      DRUGNAME  \\\n0    1076  Small molecular drug          Phase 2       AZD7325   \n1  190816  Small molecular drug    Investigative  JNJ-38158471   \n2  180551  Small molecular drug         Approved     Sunitinib   \n3   51630  Small molecular drug         Approved  Promethazine   \n4   50566  Small molecular drug         Approved    Quetiapine   \n\n         Disease_of_highest_status    Drug_Status GENENAME  \\\n0                 Anxiety disorder        Phase 2   GABRA1   \n1            Angiogenesis disorder  Investigative     FLT3   \n2  Gastrointestinal stromal tumour       Approved      MET   \n3                           Nausea       Approved     DRD2   \n4               Alcohol dependence        Phase 3     DRD2   \n\n                                            SEQUENCE  \\\n0  MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRIL...   \n1  MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSS...   \n2  MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNF...   \n3  MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...   \n4  MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...   \n\n                             Disease  \n0                            Malaria  \n1  Malignant haematopoietic neoplasm  \n2                       Liver cancer  \n3                         Depression  \n4                           Lymphoma  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>GENENAME</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>Small molecular drug</td>\n      <td>Phase 2</td>\n      <td>AZD7325</td>\n      <td>Anxiety disorder</td>\n      <td>Phase 2</td>\n      <td>GABRA1</td>\n      <td>MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRIL...</td>\n      <td>Malaria</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>Small molecular drug</td>\n      <td>Investigative</td>\n      <td>JNJ-38158471</td>\n      <td>Angiogenesis disorder</td>\n      <td>Investigative</td>\n      <td>FLT3</td>\n      <td>MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSS...</td>\n      <td>Malignant haematopoietic neoplasm</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Sunitinib</td>\n      <td>Gastrointestinal stromal tumour</td>\n      <td>Approved</td>\n      <td>MET</td>\n      <td>MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNF...</td>\n      <td>Liver cancer</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Promethazine</td>\n      <td>Nausea</td>\n      <td>Approved</td>\n      <td>DRD2</td>\n      <td>MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...</td>\n      <td>Depression</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Quetiapine</td>\n      <td>Alcohol dependence</td>\n      <td>Phase 3</td>\n      <td>DRD2</td>\n      <td>MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...</td>\n      <td>Lymphoma</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"data = pd.read_csv(\"/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/train.csv\")\ndata.drop(drop_cols, axis=1, inplace=True)\ndata.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:25:11.078494Z","iopub.execute_input":"2024-09-27T02:25:11.079011Z","iopub.status.idle":"2024-09-27T02:25:14.034072Z","shell.execute_reply.started":"2024-09-27T02:25:11.078960Z","shell.execute_reply":"2024-09-27T02:25:14.032887Z"},"trusted":true},"execution_count":24,"outputs":[{"execution_count":24,"output_type":"execute_result","data":{"text/plain":"       ID              DRUGTYPE         Drug_high_status       DRUGNAME  \\\n0  140736  Small molecular drug                 Approved    Solifenacin   \n1  133048  Small molecular drug            Investigative         AM-643   \n2   60493  Small molecular drug                  Phase 1        TAK-593   \n3  169176  Small molecular drug  Discontinued in Phase 3     PF-1913539   \n4  120183  Small molecular drug                 Approved  Ethopropazine   \n\n  Disease_of_highest_status              Drug_Status GENENAME  \\\n0        Overactive bladder                 Approved  CACNA1C   \n1    Dermatological disease            Investigative    PTGS1   \n2       Solid tumour/cancer                  Phase 1      KDR   \n3         Alzheimer disease  Discontinued in Phase 3   ADORA1   \n4         Parkinson disease                 Approved     ACHE   \n\n                                            SEQUENCE  \\\n0  MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...   \n1  MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...   \n2  MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...   \n3  MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...   \n4  MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...   \n\n                               Disease Target_Status  \n0           Genetic cardiac arrhythmia    Terminated  \n1                 Rheumatoid arthritis      Approved  \n2                 Renal cell carcinoma      Approved  \n3               Hyper-lipoproteinaemia       Phase 2  \n4  Oesophageal/gastroduodenal disorder      Approved  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>GENENAME</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n      <th>Target_Status</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>140736</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Solifenacin</td>\n      <td>Overactive bladder</td>\n      <td>Approved</td>\n      <td>CACNA1C</td>\n      <td>MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...</td>\n      <td>Genetic cardiac arrhythmia</td>\n      <td>Terminated</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>133048</td>\n      <td>Small molecular drug</td>\n      <td>Investigative</td>\n      <td>AM-643</td>\n      <td>Dermatological disease</td>\n      <td>Investigative</td>\n      <td>PTGS1</td>\n      <td>MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...</td>\n      <td>Rheumatoid arthritis</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>60493</td>\n      <td>Small molecular drug</td>\n      <td>Phase 1</td>\n      <td>TAK-593</td>\n      <td>Solid tumour/cancer</td>\n      <td>Phase 1</td>\n      <td>KDR</td>\n      <td>MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...</td>\n      <td>Renal cell carcinoma</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>169176</td>\n      <td>Small molecular drug</td>\n      <td>Discontinued in Phase 3</td>\n      <td>PF-1913539</td>\n      <td>Alzheimer disease</td>\n      <td>Discontinued in Phase 3</td>\n      <td>ADORA1</td>\n      <td>MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...</td>\n      <td>Hyper-lipoproteinaemia</td>\n      <td>Phase 2</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>120183</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Ethopropazine</td>\n      <td>Parkinson disease</td>\n      <td>Approved</td>\n      <td>ACHE</td>\n      <td>MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...</td>\n      <td>Oesophageal/gastroduodenal disorder</td>\n      <td>Approved</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"from sklearn.preprocessing import LabelEncoder\n\nfor i in le_cols:\n    le = LabelEncoder()  # Initialize LabelEncoder\n    \n    # Fit on X_train and transform X_train\n    data[i] = le.fit_transform(data[i])\n\n    # Transform test set using the same encoder fitted on X_train\n    test[i] = test[i].apply(lambda x: le.transform([x])[0] if x in le.classes_ else -1 if pd.notna(x) else -1)\n\ntest.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:25:14.036583Z","iopub.execute_input":"2024-09-27T02:25:14.036966Z","iopub.status.idle":"2024-09-27T02:29:29.106242Z","shell.execute_reply.started":"2024-09-27T02:25:14.036927Z","shell.execute_reply":"2024-09-27T02:29:29.104991Z"},"trusted":true},"execution_count":25,"outputs":[{"execution_count":25,"output_type":"execute_result","data":{"text/plain":"       ID  DRUGTYPE  Drug_high_status  DRUGNAME  Disease_of_highest_status  \\\n0    1076         4                17       153                         57   \n1  190816         4                11      1116                         53   \n2  180551         4                 0      2111                        258   \n3   51630         4                 0      1785                        447   \n4   50566         4                 0      1809                         32   \n\n   Drug_Status  GENENAME  SEQUENCE  Disease  \n0           17       262       529      331  \n1           12       253       459      334  \n2            1       412       360      318  \n3            1       202       171      152  \n4           21       202       171      328  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>GENENAME</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>4</td>\n      <td>17</td>\n      <td>153</td>\n      <td>57</td>\n      <td>17</td>\n      <td>262</td>\n      <td>529</td>\n      <td>331</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>4</td>\n      <td>11</td>\n      <td>1116</td>\n      <td>53</td>\n      <td>12</td>\n      <td>253</td>\n      <td>459</td>\n      <td>334</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>4</td>\n      <td>0</td>\n      <td>2111</td>\n      <td>258</td>\n      <td>1</td>\n      <td>412</td>\n      <td>360</td>\n      <td>318</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>4</td>\n      <td>0</td>\n      <td>1785</td>\n      <td>447</td>\n      <td>1</td>\n      <td>202</td>\n      <td>171</td>\n      <td>152</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>4</td>\n      <td>0</td>\n      <td>1809</td>\n      <td>32</td>\n      <td>21</td>\n      <td>202</td>\n      <td>171</td>\n      <td>328</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"data['Target_Status'] = le.fit_transform(data['Target_Status'])\ndata.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:29:29.107636Z","iopub.execute_input":"2024-09-27T02:29:29.107994Z","iopub.status.idle":"2024-09-27T02:29:29.154840Z","shell.execute_reply.started":"2024-09-27T02:29:29.107957Z","shell.execute_reply":"2024-09-27T02:29:29.153657Z"},"trusted":true},"execution_count":26,"outputs":[{"execution_count":26,"output_type":"execute_result","data":{"text/plain":"       ID  DRUGTYPE  Drug_high_status  DRUGNAME  Disease_of_highest_status  \\\n0  140736         4                 0      2076                        485   \n1  133048         4                11        76                        177   \n2   60493         4                14      2125                        592   \n3  169176         4                 8      1621                         41   \n4  120183         4                 0       807                        494   \n\n   Drug_Status  GENENAME  SEQUENCE  Disease  Target_Status  \n0            1        92       662      220             31  \n1           12       554       600      487              1  \n2           15       371       513      479              1  \n3            9        17       488      248             22  \n4            1         9       537      407              1  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>GENENAME</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n      <th>Target_Status</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>140736</td>\n      <td>4</td>\n      <td>0</td>\n      <td>2076</td>\n      <td>485</td>\n      <td>1</td>\n      <td>92</td>\n      <td>662</td>\n      <td>220</td>\n      <td>31</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>133048</td>\n      <td>4</td>\n      <td>11</td>\n      <td>76</td>\n      <td>177</td>\n      <td>12</td>\n      <td>554</td>\n      <td>600</td>\n      <td>487</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>60493</td>\n      <td>4</td>\n      <td>14</td>\n      <td>2125</td>\n      <td>592</td>\n      <td>15</td>\n      <td>371</td>\n      <td>513</td>\n      <td>479</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>169176</td>\n      <td>4</td>\n      <td>8</td>\n      <td>1621</td>\n      <td>41</td>\n      <td>9</td>\n      <td>17</td>\n      <td>488</td>\n      <td>248</td>\n      <td>22</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>120183</td>\n      <td>4</td>\n      <td>0</td>\n      <td>807</td>\n      <td>494</td>\n      <td>1</td>\n      <td>9</td>\n      <td>537</td>\n      <td>407</td>\n      <td>1</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"le.classes_","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:29:29.157083Z","iopub.execute_input":"2024-09-27T02:29:29.157457Z","iopub.status.idle":"2024-09-27T02:29:29.164547Z","shell.execute_reply.started":"2024-09-27T02:29:29.157418Z","shell.execute_reply":"2024-09-27T02:29:29.163363Z"},"trusted":true},"execution_count":27,"outputs":[{"execution_count":27,"output_type":"execute_result","data":{"text/plain":"array(['Application submitted', 'Approved', 'Approved (orphan drug)',\n       'BLA submitted', 'Clinical trial', 'Discontinued in Phase 1',\n       'Discontinued in Phase 1/2', 'Discontinued in Phase 2',\n       'Discontinued in Phase 2/3', 'Discontinued in Phase 2b',\n       'Discontinued in Phase 3', 'Discontinued in Phase 4',\n       'Discontinued in Preregistration', 'IND submitted',\n       'Investigative', 'Patented', 'Phase 0', 'Phase 1', 'Phase 1/2',\n       'Phase 1/2a', 'Phase 1b', 'Phase 1b/2a', 'Phase 2', 'Phase 2/3',\n       'Phase 2a', 'Phase 2b', 'Phase 3', 'Phase 4', 'Preclinical',\n       'Preregistration', 'Registered', 'Terminated',\n       'Withdrawn from market'], dtype=object)"},"metadata":{}}]},{"cell_type":"code","source":"# Define the list of categories in the order you want to encode them\ncategories = [\n    'Application submitted', 'Approved', 'Approved (orphan drug)', 'BLA submitted', 'Clinical trial',\n    'Discontinued in Phase 1', 'Discontinued in Phase 1/2', 'Discontinued in Phase 2', 'Discontinued in Phase 2/3',\n    'Discontinued in Phase 2b', 'Discontinued in Phase 3', 'Discontinued in Phase 4',\n    'Discontinued in Preregistration', 'IND submitted', 'Investigative', 'Patented', 'Phase 0', 'Phase 1', 'Phase 1/2',\n    'Phase 1/2a', 'Phase 1b', 'Phase 1b/2a', 'Phase 2', 'Phase 2/3', 'Phase 2a', 'Phase 2b', 'Phase 3', 'Phase 4',\n    'Preclinical', 'Preregistration', 'Registered', 'Terminated', 'Withdrawn from market'\n]\n\n# Create a dictionary mapping each category to its corresponding label (0, 1, 2, etc.)\ncategory_to_label = {idx : category for idx, category in enumerate(categories)}\n\n# Function to apply the mapping\n# def map_to_label(value):\n#     return category_to_label.get(value, 1)  # Returns 1 if the value is not found in the dictionary\ncategory_to_label","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:29:29.166058Z","iopub.execute_input":"2024-09-27T02:29:29.166455Z","iopub.status.idle":"2024-09-27T02:29:29.179613Z","shell.execute_reply.started":"2024-09-27T02:29:29.166414Z","shell.execute_reply":"2024-09-27T02:29:29.178378Z"},"trusted":true},"execution_count":28,"outputs":[{"execution_count":28,"output_type":"execute_result","data":{"text/plain":"{0: 'Application submitted',\n 1: 'Approved',\n 2: 'Approved (orphan drug)',\n 3: 'BLA submitted',\n 4: 'Clinical trial',\n 5: 'Discontinued in Phase 1',\n 6: 'Discontinued in Phase 1/2',\n 7: 'Discontinued in Phase 2',\n 8: 'Discontinued in Phase 2/3',\n 9: 'Discontinued in Phase 2b',\n 10: 'Discontinued in Phase 3',\n 11: 'Discontinued in Phase 4',\n 12: 'Discontinued in Preregistration',\n 13: 'IND submitted',\n 14: 'Investigative',\n 15: 'Patented',\n 16: 'Phase 0',\n 17: 'Phase 1',\n 18: 'Phase 1/2',\n 19: 'Phase 1/2a',\n 20: 'Phase 1b',\n 21: 'Phase 1b/2a',\n 22: 'Phase 2',\n 23: 'Phase 2/3',\n 24: 'Phase 2a',\n 25: 'Phase 2b',\n 26: 'Phase 3',\n 27: 'Phase 4',\n 28: 'Preclinical',\n 29: 'Preregistration',\n 30: 'Registered',\n 31: 'Terminated',\n 32: 'Withdrawn from market'}"},"metadata":{}}]},{"cell_type":"code","source":"X = data.drop('Target_Status', axis=1)\ny = data['Target_Status']\n\n# param = {use_label_encoder=False, eval_metric='mlogloss'} # (1st submission - baseline) - 0.94986\n# param = {'max_depth': 10, 'learning_rate': 0.09887667319531757, 'n_estimators': 286,\n#          'subsample': 0.8818473315577697, 'colsample_bytree': 0.7911835582470869, \n#          'gamma': 0.5882283567417588, 'min_child_weight': 1} # after removing features (2nd submission) - 0.96608\n# param = {'max_depth': 10, 'learning_rate': 0.09887667319531757, 'n_estimators': 286,\n#          'subsample': 0.8818473315577697, 'colsample_bytree': 0.7911835582470869, \n#          'gamma': 0.5882283567417588, 'min_child_weight': 1} # nothing dropped (3rd submission) - 0.776608\n# params = {'max_depth': 17, 'learning_rate': 0.0663028870385258, 'n_estimators': 409,\n#           'subsample': 0.9629463287306949, 'colsample_bytree': 0.8300614936416831,\n#           'gamma': 0.2857062337129327, 'min_child_weight': 3} # 4th submission - 0.96506\n# params = {'max_depth': 18, 'learning_rate': 0.02554741000702669, 'n_estimators': 418, \n#           'subsample': 0.9899632082718985, 'colsample_bytree': 0.8226626583591214, \n#           'gamma': 0.9701683008405076, 'min_child_weight': 3}  # 0.965149\n\nimport xgboost as xgb\n\nmodel = xgb.XGBClassifier(**params)\n\nmodel.fit(X, y)\n\npreds = model.predict(test)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:33:50.900385Z","iopub.execute_input":"2024-09-27T02:33:50.900740Z","iopub.status.idle":"2024-09-27T02:38:12.760004Z","shell.execute_reply.started":"2024-09-27T02:33:50.900702Z","shell.execute_reply":"2024-09-27T02:38:12.758794Z"},"trusted":true},"execution_count":30,"outputs":[]},{"cell_type":"code","source":"t = pd.read_csv(\"/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/test.csv\")\nt.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:38:12.761440Z","iopub.execute_input":"2024-09-27T02:38:12.761790Z","iopub.status.idle":"2024-09-27T02:38:14.084696Z","shell.execute_reply.started":"2024-09-27T02:38:12.761754Z","shell.execute_reply":"2024-09-27T02:38:14.083486Z"},"trusted":true},"execution_count":31,"outputs":[{"execution_count":31,"output_type":"execute_result","data":{"text/plain":"       ID TargetID  DRUGID              DRUGTYPE Drug_high_status  \\\n0    1076   T51487  D0HO2T  Small molecular drug          Phase 2   \n1  190816   T74312  D0Q4EQ  Small molecular drug    Investigative   \n2  180551   T40474  D0R0MW  Small molecular drug         Approved   \n3   51630   T67162  D0T2XU  Small molecular drug         Approved   \n4   50566   T67162  D0H7KF  Small molecular drug         Approved   \n\n       DRUGNAME  PUBCHCID        Disease_of_highest_status    Drug_Status  \\\n0       AZD7325  23581869                 Anxiety disorder        Phase 2   \n1  JNJ-38158471  16742063            Angiogenesis disorder  Investigative   \n2     Sunitinib   5329102  Gastrointestinal stromal tumour       Approved   \n3  Promethazine      4927                           Nausea       Approved   \n4    Quetiapine      5002               Alcohol dependence        Phase 3   \n\n      UNIPROID                            TARGNAME GENENAME  \\\n0  GBRA1_HUMAN   GABA(A) receptor alpha-1 (GABRA1)   GABRA1   \n1   FLT3_HUMAN  Fms-like tyrosine kinase 3 (FLT-3)     FLT3   \n2    MET_HUMAN          Proto-oncogene c-Met (MET)      MET   \n3   DRD2_HUMAN          Dopamine D2 receptor (D2R)     DRD2   \n4   DRD2_HUMAN          Dopamine D2 receptor (D2R)     DRD2   \n\n                                            SYNONYMS  \\\n0  Gamma-aminobutyric acid receptor subunit alpha...   \n1  Stem cell tyrosine kinase 1; STK1; STK-1; Rece...   \n2  Tyrosine-protein kinase Met; Scatter factor re...   \n3        Dopamine receptor 2; D(2) dopamine receptor   \n4        Dopamine receptor 2; D(2) dopamine receptor   \n\n                                            FUNCTION  \\\n0  Ligand-gated chloride channel which is a compo...   \n1  Tyrosine-protein kinase that acts as cell-surf...   \n2  Regulates many physiological processes includi...   \n3  Dopamine receptor whose activity is mediated b...   \n4  Dopamine receptor whose activity is mediated b...   \n\n                   BIOCLASS  \\\n0  Ligand-gated ion channel   \n1                    Kinase   \n2                    Kinase   \n3            GPCR rhodopsin   \n4            GPCR rhodopsin   \n\n                                            SEQUENCE  \\\n0  MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRIL...   \n1  MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSS...   \n2  MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNF...   \n3  MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...   \n4  MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...   \n\n                             Disease Accession Number  \n0                            Malaria           P14867  \n1  Malignant haematopoietic neoplasm           P36888  \n2                       Liver cancer           Q86W50  \n3                         Depression           P14416  \n4                           Lymphoma           P14416  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>TargetID</th>\n      <th>DRUGID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>PUBCHCID</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>UNIPROID</th>\n      <th>TARGNAME</th>\n      <th>GENENAME</th>\n      <th>SYNONYMS</th>\n      <th>FUNCTION</th>\n      <th>BIOCLASS</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n      <th>Accession Number</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>T51487</td>\n      <td>D0HO2T</td>\n      <td>Small molecular drug</td>\n      <td>Phase 2</td>\n      <td>AZD7325</td>\n      <td>23581869</td>\n      <td>Anxiety disorder</td>\n      <td>Phase 2</td>\n      <td>GBRA1_HUMAN</td>\n      <td>GABA(A) receptor alpha-1 (GABRA1)</td>\n      <td>GABRA1</td>\n      <td>Gamma-aminobutyric acid receptor subunit alpha...</td>\n      <td>Ligand-gated chloride channel which is a compo...</td>\n      <td>Ligand-gated ion channel</td>\n      <td>MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRIL...</td>\n      <td>Malaria</td>\n      <td>P14867</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>T74312</td>\n      <td>D0Q4EQ</td>\n      <td>Small molecular drug</td>\n      <td>Investigative</td>\n      <td>JNJ-38158471</td>\n      <td>16742063</td>\n      <td>Angiogenesis disorder</td>\n      <td>Investigative</td>\n      <td>FLT3_HUMAN</td>\n      <td>Fms-like tyrosine kinase 3 (FLT-3)</td>\n      <td>FLT3</td>\n      <td>Stem cell tyrosine kinase 1; STK1; STK-1; Rece...</td>\n      <td>Tyrosine-protein kinase that acts as cell-surf...</td>\n      <td>Kinase</td>\n      <td>MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSS...</td>\n      <td>Malignant haematopoietic neoplasm</td>\n      <td>P36888</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>T40474</td>\n      <td>D0R0MW</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Sunitinib</td>\n      <td>5329102</td>\n      <td>Gastrointestinal stromal tumour</td>\n      <td>Approved</td>\n      <td>MET_HUMAN</td>\n      <td>Proto-oncogene c-Met (MET)</td>\n      <td>MET</td>\n      <td>Tyrosine-protein kinase Met; Scatter factor re...</td>\n      <td>Regulates many physiological processes includi...</td>\n      <td>Kinase</td>\n      <td>MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNF...</td>\n      <td>Liver cancer</td>\n      <td>Q86W50</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>T67162</td>\n      <td>D0T2XU</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Promethazine</td>\n      <td>4927</td>\n      <td>Nausea</td>\n      <td>Approved</td>\n      <td>DRD2_HUMAN</td>\n      <td>Dopamine D2 receptor (D2R)</td>\n      <td>DRD2</td>\n      <td>Dopamine receptor 2; D(2) dopamine receptor</td>\n      <td>Dopamine receptor whose activity is mediated b...</td>\n      <td>GPCR rhodopsin</td>\n      <td>MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...</td>\n      <td>Depression</td>\n      <td>P14416</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>T67162</td>\n      <td>D0H7KF</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Quetiapine</td>\n      <td>5002</td>\n      <td>Alcohol dependence</td>\n      <td>Phase 3</td>\n      <td>DRD2_HUMAN</td>\n      <td>Dopamine D2 receptor (D2R)</td>\n      <td>DRD2</td>\n      <td>Dopamine receptor 2; D(2) dopamine receptor</td>\n      <td>Dopamine receptor whose activity is mediated b...</td>\n      <td>GPCR rhodopsin</td>\n      <td>MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIA...</td>\n      <td>Lymphoma</td>\n      <td>P14416</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"sub = pd.DataFrame()\nsub['ID'] = t['ID']\nsub['Prediction'] = preds\nsub.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:38:14.086003Z","iopub.execute_input":"2024-09-27T02:38:14.086402Z","iopub.status.idle":"2024-09-27T02:38:14.105232Z","shell.execute_reply.started":"2024-09-27T02:38:14.086362Z","shell.execute_reply":"2024-09-27T02:38:14.104095Z"},"trusted":true},"execution_count":32,"outputs":[{"execution_count":32,"output_type":"execute_result","data":{"text/plain":"       ID  Prediction\n0    1076           1\n1  190816          26\n2  180551          26\n3   51630           1\n4   50566          18","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>Prediction</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>26</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>26</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>18</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"sub['Prediction'] = sub['Prediction'].map(category_to_label)\nsub.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:38:14.109048Z","iopub.execute_input":"2024-09-27T02:38:14.109522Z","iopub.status.idle":"2024-09-27T02:38:14.126360Z","shell.execute_reply.started":"2024-09-27T02:38:14.109484Z","shell.execute_reply":"2024-09-27T02:38:14.125031Z"},"trusted":true},"execution_count":33,"outputs":[{"execution_count":33,"output_type":"execute_result","data":{"text/plain":"       ID Prediction\n0    1076   Approved\n1  190816    Phase 3\n2  180551    Phase 3\n3   51630   Approved\n4   50566  Phase 1/2","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>Prediction</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>Phase 3</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>Phase 3</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>Phase 1/2</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"sub.to_csv('XGB_optuna_4thSUBMISSION.csv', index=False)\nlen(sub)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:38:14.128427Z","iopub.execute_input":"2024-09-27T02:38:14.128778Z","iopub.status.idle":"2024-09-27T02:38:14.206317Z","shell.execute_reply.started":"2024-09-27T02:38:14.128742Z","shell.execute_reply":"2024-09-27T02:38:14.205084Z"},"trusted":true},"execution_count":34,"outputs":[{"execution_count":34,"output_type":"execute_result","data":{"text/plain":"57637"},"metadata":{}}]},{"cell_type":"code","source":"print(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:38:14.207664Z","iopub.execute_input":"2024-09-27T02:38:14.207998Z","iopub.status.idle":"2024-09-27T02:38:14.214320Z","shell.execute_reply.started":"2024-09-27T02:38:14.207963Z","shell.execute_reply":"2024-09-27T02:38:14.213028Z"},"trusted":true},"execution_count":35,"outputs":[{"name":"stdout","text":"Done\n","output_type":"stream"}]},{"cell_type":"markdown","source":"# Feature and Param Importances","metadata":{}},{"cell_type":"code","source":"import matplotlib.pyplot as plt\nimport pandas as pd\n\n# Extract feature importances\nfeature_importances = model.feature_importances_\nfeatures = X_train.columns\n\n# Create a DataFrame for better visualization\nimportance_df = pd.DataFrame({\n    'Feature': features,\n    'Importance': feature_importances\n})\n\n# Sort by importance\nimportance_df = importance_df.sort_values(by='Importance', ascending=False)\n\n# Plot\nplt.figure(figsize=(10, 6))\nbars = plt.barh(importance_df['Feature'], importance_df['Importance'], color='skyblue')\nplt.xlabel('Feature Importance')\nplt.ylabel('Features')\nplt.title('Feature Importance Plot')\nplt.gca().invert_yaxis()  # Invert y-axis to have most important at the top\n\n# Annotate each bar with the importance value\nfor bar in bars:\n    width = bar.get_width()\n    plt.text(width, bar.get_y() + bar.get_height()/2, f'{width:.2f}', va='center')\n\nplt.show()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T02:42:13.108573Z","iopub.execute_input":"2024-09-27T02:42:13.109610Z","iopub.status.idle":"2024-09-27T02:42:13.418241Z","shell.execute_reply.started":"2024-09-27T02:42:13.109559Z","shell.execute_reply":"2024-09-27T02:42:13.417131Z"},"trusted":true},"execution_count":37,"outputs":[{"output_type":"display_data","data":{"text/plain":"<Figure size 1000x600 with 1 Axes>","image/png":"iVBORw0KGgoAAAANSUhEUgAAA+8AAAIjCAYAAAByJypeAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuNSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/xnp5ZAAAACXBIWXMAAA9hAAAPYQGoP6dpAACDm0lEQVR4nOzdeVwVZf//8fcBFGQHUUAiERdwxQU1zdxC0cLU3LJMwNQWd9JQS9wyzNTU3Fo09b7VTDMrU+7cyBbTXLNSstQwBSxTUElUOL8//HG+nQBFBBnz9Xw85nFzrrnmms8cJm/e55qZYzKbzWYBAAAAAADDsintAgAAAAAAwPUR3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAHBHCggIUFRUVGmXAQC3BeEdAIC7zJIlS2QymfJdRo8eXSL7/PrrrzVhwgSdO3euRMa/Fbnvx+7du0u7lCKbP3++lixZUtplFJu/n5M2NjaqVKmS2rdvr8TExGIZ/9SpU5owYYL2799fLOMBwO1gV9oFAACA0jFp0iRVqVLFqq1OnTolsq+vv/5aEydOVFRUlNzd3UtkH3ez+fPny8vL6181C92uXTv17dtXZrNZx44d0/z589W2bVt9+umn6tix4y2NferUKU2cOFEBAQGqX79+8RQMACWM8A4AwF2qY8eOCg0NLe0ybsnFixfl5ORU2mWUmszMTDk6OpZ2GSWiRo0a6tOnj+V1165dVa9ePc2aNeuWwzsA3Im4bB4AAORr48aNeuCBB+Tk5CQXFxc9/PDD+uGHH6z6fPfdd4qKilJgYKAcHBzk4+Ojfv366cyZM5Y+EyZM0KhRoyRJVapUsVwOffz4cR0/flwmkynfS75NJpMmTJhgNY7JZNKPP/6oxx9/XB4eHmrRooVl/X//+181atRI5cqVk6enpx577DGdOHGiSMceFRUlZ2dnJScnKyIiQs7OzvLz89O8efMkSQcPHlTbtm3l5OSkypUra8WKFVbb516Kv337dj399NMqX768XF1d1bdvX509ezbP/ubPn6/atWvL3t5elSpV0qBBg/LcYtC6dWvVqVNHe/bsUcuWLeXo6KixY8cqICBAP/zwgz7//HPLe9u6dWtJ0p9//qmRI0eqbt26cnZ2lqurqzp27KgDBw5YjZ2YmCiTyaT3339fU6ZM0T333CMHBwc9+OCD+vnnn/PUu3PnTj300EPy8PCQk5OT6tWrp9mzZ1v1OXz4sLp37y5PT085ODgoNDRUH3/88c3+Kizq1q0rLy8vHTt27Lr9jh49qh49esjT01OOjo6677779Omnn1oda+PGjSVJ0dHRlvfs33TbAYB/J2beAQC4S6Wnp+uPP/6wavPy8pIk/ec//1FkZKTCw8P16quvKjMzUwsWLFCLFi20b98+BQQESJI2bdqko0ePKjo6Wj4+Pvrhhx/01ltv6YcfftA333wjk8mkRx99VD/99JNWrlyp119/3bKPChUq6Pfff7/punv06KHq1avrlVdekdlsliRNmTJF48aNU8+ePdW/f3/9/vvveuONN9SyZUvt27evSJfqZ2dnq2PHjmrZsqWmTZum5cuXa/DgwXJyctKLL76oJ554Qo8++qgWLlyovn37qlmzZnluQxg8eLDc3d01YcIEJSUlacGCBfr1118tYVm69qHExIkTFRYWpmeffdbS79tvv9VXX32lMmXKWMY7c+aMOnbsqMcee0x9+vSRt7e3WrdurSFDhsjZ2VkvvviiJMnb21vStSC7bt069ejRQ1WqVFFaWprefPNNtWrVSj/++KMqVapkVe/UqVNlY2OjkSNHKj09XdOmTdMTTzyhnTt3Wvps2rRJERER8vX11bBhw+Tj46NDhw5p/fr1GjZsmCTphx9+0P333y8/Pz+NHj1aTk5Oev/999WlSxd98MEH6tq1603/Ps6ePauzZ8+qWrVqBfZJS0tT8+bNlZmZqaFDh6p8+fJaunSpHnnkEa1Zs0Zdu3ZVzZo1NWnSJMXFxWngwIF64IEHJEnNmze/6ZoA4LYyAwCAu8q7775rlpTvYjabzefPnze7u7ubBwwYYLVdamqq2c3Nzao9MzMzz/grV640SzJv377d0vbaa6+ZJZmPHTtm1ffYsWNmSeZ33303zziSzOPHj7e8Hj9+vFmSuXfv3lb9jh8/bra1tTVPmTLFqv3gwYNmOzu7PO0FvR/ffvutpS0yMtIsyfzKK69Y2s6ePWsuV66c2WQymd977z1L++HDh/PUmjtmo0aNzJcvX7a0T5s2zSzJ/NFHH5nNZrP59OnT5rJly5rbt29vzs7OtvSbO3euWZJ58eLFlrZWrVqZJZkXLlyY5xhq165tbtWqVZ72S5cuWY1rNl97z+3t7c2TJk2ytG3bts0syVyzZk1zVlaWpX327NlmSeaDBw+azWaz+erVq+YqVaqYK1eubD579qzVuDk5OZafH3zwQXPdunXNly5dslrfvHlzc/Xq1fPU+U+SzE899ZT5999/N58+fdq8c+dO84MPPmiWZJ4xY4alX+XKlc2RkZGW18OHDzdLMn/xxReWtvPnz5urVKliDggIsLwX3377bYHnHQAYFZfNAwBwl5o3b542bdpktUjXZlbPnTun3r17648//rAstra2atq0qbZt22YZo1y5cpafL126pD/++EP33XefJGnv3r0lUvczzzxj9Xrt2rXKyclRz549rer18fFR9erVreq9Wf3797f87O7urqCgIDk5Oalnz56W9qCgILm7u+vo0aN5th84cKDVzPmzzz4rOzs7bdiwQZK0efNmXb58WcOHD5eNzf/9WTZgwAC5urpaXe4tSfb29oqOji50/fb29pZxs7OzdebMGTk7OysoKCjf3090dLTKli1reZ07K517bPv27dOxY8c0fPjwPFcz5F5J8Oeff2rr1q3q2bOnzp8/b/l9nDlzRuHh4Tpy5IhOnjx5w9oXLVqkChUqqGLFimratKm++uorxcTEaPjw4QVus2HDBjVp0sTqdgpnZ2cNHDhQx48f148//njD/QKAUXHZPAAAd6kmTZrk+8C6I0eOSJLatm2b73aurq6Wn//8809NnDhR7733nk6fPm3VLz09vRir/T//vDT9yJEjMpvNql69er79/x6eb4aDg4MqVKhg1ebm5qZ77rnHElT/3p7fvez/rMnZ2Vm+vr46fvy4JOnXX3+VdO0DgL8rW7asAgMDLetz+fn5WYXrG8nJydHs2bM1f/58HTt2TNnZ2ZZ15cuXz9P/3nvvtXrt4eEhSZZj++WXXyRd/1sJfv75Z5nNZo0bN07jxo3Lt8/p06fl5+d33do7d+6swYMHy2QyycXFRbVr177hwwl//fVXNW3aNE97zZo1LetL6hsVAKCkEd4BAICVnJwcSdfue/fx8cmz3s7u//586Nmzp77++muNGjVK9evXl7Ozs3JyctShQwfLONfzzxCc6+8h85/+PtufW6/JZNLGjRtla2ubp7+zs/MN68hPfmNdr938/++/L0n/PPYbeeWVVzRu3Dj169dPkydPlqenp2xsbDR8+PB8fz/FcWy5444cOVLh4eH59rnefeu57rnnHoWFhRV6vwDwb0d4BwAAVqpWrSpJqlix4nXD09mzZ7VlyxZNnDhRcXFxlvbcmfu/Kyik587s/vPJ6v+ccb5RvWazWVWqVFGNGjUKvd3tcOTIEbVp08by+sKFC0pJSdFDDz0kSapcubIkKSkpSYGBgZZ+ly9f1rFjxwodXgt6f9esWaM2bdpo0aJFVu3nzp2zPDjwZuSeG99//32BteUeR5kyZW57+K5cubKSkpLytB8+fNiyXir4/QIAI+OedwAAYCU8PFyurq565ZVXdOXKlTzrc58QnztL+89Z2VmzZuXZJvdy53+GdFdXV3l5eWn79u1W7fPnzy90vY8++qhsbW01ceLEPLWYzWarr6273d566y2r93DBggW6evWq5XvKw8LCVLZsWc2ZM8eq9kWLFik9PV0PP/xwofbj5OSU572Vrv2O/vmerF69ulD3nOenYcOGqlKlimbNmpVnf7n7qVixolq3bq0333xTKSkpecYoyjcMFNZDDz2kXbt2aceOHZa2ixcv6q233lJAQIBq1aolqeDzEQCMjJl3AABgxdXVVQsWLNCTTz6phg0b6rHHHlOFChWUnJysTz/9VPfff7/mzp0rV1dXy9eoXblyRX5+fvrss8/y/R7uRo0aSZJefPFFPfbYYypTpow6deokJycn9e/fX1OnTlX//v0VGhqq7du366effip0vVWrVtXLL7+sMWPG6Pjx4+rSpYtcXFx07Ngxffjhhxo4cKBGjhxZbO/Pzbh8+bIefPBB9ezZU0lJSZo/f75atGihRx55RNK1r8sbM2aMJk6cqA4dOuiRRx6x9GvcuLH69OlTqP00atRICxYs0Msvv6xq1aqpYsWKatu2rSIiIjRp0iRFR0erefPmOnjwoJYvX241y38zbGxstGDBAnXq1En169dXdHS0fH19dfjwYf3www/63//+J+nawxBbtGihunXrasCAAQoMDFRaWpp27Nih3377Lc/3zBeX0aNHa+XKlerYsaOGDh0qT09PLV26VMeOHdMHH3xgeXhf1apV5e7uroULF8rFxUVOTk5q2rRpnucpAICREN4BAEAejz/+uCpVqqSpU6fqtddeU1ZWlvz8/PTAAw9YPe18xYoVGjJkiObNmyez2az27dtr48aNeb4/vHHjxpo8ebIWLlyohIQE5eTk6NixY3JyclJcXJx+//13rVmzRu+//746duyojRs3qmLFioWud/To0apRo4Zef/11TZw4UZLk7++v9u3bW4JyaZg7d66WL1+uuLg4XblyRb1799acOXOsLtueMGGCKlSooLlz52rEiBHy9PTUwIED9corrxT6YXtxcXH69ddfNW3aNJ0/f16tWrVS27ZtNXbsWF28eFErVqzQqlWr1LBhQ3366acaPXp0kY8pPDxc27Zt08SJEzVjxgzl5OSoatWqGjBggKVPrVq1tHv3bk2cOFFLlizRmTNnVLFiRTVo0MDqFovi5u3tra+//lqxsbF64403dOnSJdWrV0+ffPKJ1VUMZcqU0dKlSzVmzBg988wzunr1qt59913COwBDM5lvx9NVAAAA7iJLlixRdHS0vv3223yf6A8AwM3inncAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjueQcAAAAAwOCYeQcAAAAAwOAI7wAAAAAAGBzf8w7cZjk5OTp16pRcXFysvucXAAAAwN3FbDbr/PnzqlSpkmxsrj+3TngHbrNTp07J39+/tMsAAAAAYBAnTpzQPffcc90+hHfgNnNxcZF07T9QV1fXUq4GAAAAQGnJyMiQv7+/JSNcD+EduM1yL5V3dXUlvAMAAAAo1O20PLAOAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwdqVdAHC3mnngjBycL5d2GQAAAMBdY3QDr9IuociYeQcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAMBdZ968eQoICJCDg4OaNm2qXbt2Fdj37bff1gMPPCAPDw95eHgoLCwsT/+oqCiZTCarpUOHDsVWL+EdhmcymbRu3brSLgMAAADAv8SqVasUExOj8ePHa+/evQoJCVF4eLhOnz6db//ExET17t1b27Zt044dO+Tv76/27dvr5MmTVv06dOiglJQUy7Jy5cpiq5nwjlLz90+mypQpI29vb7Vr106LFy9WTk6OpV9KSoo6duxYipUCAAAA+DeZOXOmBgwYoOjoaNWqVUsLFy6Uo6OjFi9enG//5cuX67nnnlP9+vUVHBysd955Rzk5OdqyZYtVP3t7e/n4+FgWDw+PYquZ8I5SlfvJ1PHjx7Vx40a1adNGw4YNU0REhK5evSpJ8vHxkb29fSlXCgAAAODf4PLly9qzZ4/CwsIsbTY2NgoLC9OOHTsKNUZmZqauXLkiT09Pq/bExERVrFhRQUFBevbZZ3XmzJliq5vwjlKV+8mUn5+fGjZsqLFjx+qjjz7Sxo0btWTJEknWl81fvnxZgwcPlq+vrxwcHFS5cmXFx8dbxjt37pz69++vChUqyNXVVW3bttWBAwcs63/55Rd17txZ3t7ecnZ2VuPGjbV582armubPn6/q1avLwcFB3t7e6t69u2VdTk6O4uPjVaVKFZUrV04hISFas2ZNyb1BAAAAAIrVH3/8oezsbHl7e1u1e3t7KzU1tVBjxMbGqlKlSlYfAHTo0EHLli3Tli1b9Oqrr+rzzz9Xx44dlZ2dXSx12xXLKEAxatu2rUJCQrR27Vr179/fat2cOXP08ccf6/3339e9996rEydO6MSJE5b1PXr0ULly5bRx40a5ubnpzTff1IMPPqiffvpJnp6eunDhgh566CFNmTJF9vb2WrZsmTp16qSkpCTde++92r17t4YOHar//Oc/at68uf7880998cUXlvHj4+P13//+VwsXLlT16tW1fft29enTRxUqVFCrVq3yPZ6srCxlZWVZXmdkZBTzOwYAAADgdpk6daree+89JSYmysHBwdL+2GOPWX6uW7eu6tWrp6pVqyoxMVEPPvjgLe+X8A5DCg4O1nfffZenPTk5WdWrV1eLFi1kMplUuXJly7ovv/xSu3bt0unTpy2X2U+fPl3r1q3TmjVrNHDgQIWEhCgkJMSyzeTJk/Xhhx/q448/1uDBg5WcnCwnJydFRETIxcVFlStXVoMGDSRdC+GvvPKKNm/erGbNmkmSAgMD9eWXX+rNN98sMLzHx8dr4sSJxfbeAAAAACg6Ly8v2draKi0tzao9LS1NPj4+1912+vTpmjp1qjZv3qx69epdt29gYKC8vLz0888/F0t457J5GJLZbJbJZMrTHhUVpf379ysoKEhDhw7VZ599Zll34MABXbhwQeXLl5ezs7NlOXbsmH755RdJ0oULFzRy5EjVrFlT7u7ucnZ21qFDh5ScnCxJateunSpXrqzAwEA9+eSTWr58uTIzMyVJP//8szIzM9WuXTur8ZctW2YZPz9jxoxRenq6Zfn7lQIAAAAAbq+yZcuqUaNGVg+by334XO4kXX6mTZumyZMnKyEhQaGhoTfcz2+//aYzZ87I19e3WOpm5h2GdOjQIVWpUiVPe8OGDXXs2DFt3LhRmzdvVs+ePRUWFqY1a9bowoUL8vX1VWJiYp7t3N3dJUkjR47Upk2bNH36dFWrVk3lypVT9+7ddfnyZUmSi4uL9u7dq8TERH322WeKi4vThAkT9O233+rChQuSpE8//VR+fn5W41/vgXr29vY8cA8AAAAwkJiYGEVGRio0NFRNmjTRrFmzdPHiRUVHR0uS+vbtKz8/P8vztV599VXFxcVpxYoVCggIsNwbnzuhd+HCBU2cOFHdunWTj4+PfvnlF73wwguqVq2awsPDi6VmwjsMZ+vWrTp48KBGjBiR73pXV1f16tVLvXr1Uvfu3dWhQwf9+eefatiwoVJTU2VnZ6eAgIB8t/3qq68UFRWlrl27Sro2E3/8+HGrPnZ2dgoLC1NYWJjGjx8vd3d3bd26Ve3atZO9vb2Sk5MLvEQeAAAAgPH16tVLv//+u+Li4pSamqr69esrISHB8hC75ORk2dj834XqCxYs0OXLl60eZi1J48eP14QJE2Rra6vvvvtOS5cu1blz51SpUiW1b99ekydPLraJPMI7SlVWVpZSU1OVnZ2ttLQ0JSQkKD4+XhEREerbt2+e/jNnzpSvr68aNGggGxsbrV69Wj4+PnJ3d1dYWJiaNWumLl26aNq0aapRo4ZOnTqlTz/9VF27dlVoaKiqV6+utWvXqlOnTjKZTBo3bpzVd8qvX79eR48eVcuWLeXh4aENGzYoJydHQUFBcnFx0ciRIzVixAjl5OSoRYsWSk9P11dffSVXV1dFRkbezrcOAAAAwC0YPHiwBg8enO+6f17N+88Jv38qV66c/ve//xVTZfkjvKNUJSQkyNfXV3Z2dvLw8FBISIjmzJmjyMhIq0+6crm4uGjatGk6cuSIbG1t1bhxY23YsMHSd8OGDXrxxRcVHR2t33//XT4+PmrZsqXlE7SZM2eqX79+at68uby8vBQbG2v19Hd3d3etXbtWEyZM0KVLl1S9enWtXLlStWvXlnTtAXcVKlRQfHy8jh49Knd3d8tX3AEAAABASTGZzWZzaRcB3E0yMjLk5uam8duPysHZpbTLAQAAAO4aoxt4lXYJVnKzQXp6ulxdXa/bl6fNAwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4u9IuALhbxYSUl6ura2mXAQAAAOAOwMw7AAAAAAAGR3gHAAAAAMDgCO8AAAAAABgc4R0AAAAAAIMjvAMAAAAAYHCEdwAAAAAADI7wDgAAAACAwRHeAQAAAAAwOLvSLgC4W808cEYOzpdLuwwAAABDGt3Aq7RLAAyFmXcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAxt3rx5CggIkIODg5o2bapdu3YV2Pftt9/WAw88IA8PD3l4eCgsLCxPf7PZrLi4OPn6+qpcuXIKCwvTkSNHSvowgFtCeAcAAABgWKtWrVJMTIzGjx+vvXv3KiQkROHh4Tp9+nS+/RMTE9W7d29t27ZNO3bskL+/v9q3b6+TJ09a+kybNk1z5szRwoULtXPnTjk5OSk8PFyXLl26XYcF3DTCO64rNTVVw4YNU7Vq1eTg4CBvb2/df//9WrBggTIzMyVJAQEBMplMeZapU6dKko4fPy6TyaSKFSvq/PnzVuPXr19fEyZMsLxu3bp1vmM988wzlj4mk0kODg769ddfrcbq0qWLoqKi8hzDjh07ZGtrq4cffjjPutzabG1trf5Bl6SUlBTZ2dnJZDLp+PHjVv3zW7755ptCv68AAAAonJkzZ2rAgAGKjo5WrVq1tHDhQjk6Omrx4sX59l++fLmee+451a9fX8HBwXrnnXeUk5OjLVu2SLo26z5r1iy99NJL6ty5s+rVq6dly5bp1KlTWrdu3W08MuDmEN5RoKNHj6pBgwb67LPP9Morr2jfvn3asWOHXnjhBa1fv16bN2+29J00aZJSUlKsliFDhliNd/78eU2fPv2G+x0wYECesaZNm2bVx2QyKS4urlDHsWjRIg0ZMkTbt2/XqVOn8u3j5+enZcuWWbUtXbpUfn5++fbfvHlznhobNWpUqHoAAABQOJcvX9aePXsUFhZmabOxsVFYWJh27NhRqDEyMzN15coVeXp6SpKOHTum1NRUqzHd3NzUtGnTQo8JlAbCOwr03HPPyc7OTrt371bPnj1Vs2ZNBQYGqnPnzvr000/VqVMnS18XFxf5+PhYLU5OTlbjDRkyRDNnzizwEqdcjo6OecZydXW16jN48GD997//1ffff3/dsS5cuKBVq1bp2Wef1cMPP6wlS5bk2y8yMlLvvvuuVdu7776ryMjIfPuXL18+T41lypS5bi0AAAC4OX/88Yeys7Pl7e1t1e7t7a3U1NRCjREbG6tKlSpZwnrudrcyJlAaCO/I15kzZ/TZZ59p0KBBeUJ4LpPJdFNj9u7dW9WqVdOkSZNuub77779fERERGj169HX7vf/++woODlZQUJD69OmjxYsXy2w25+n3yCOP6OzZs/ryyy8lSV9++aXOnj1r9QFFUWVlZSkjI8NqAQAAQMmbOnWq3nvvPX344YdycHAo7XKAW0J4R75+/vlnmc1mBQUFWbV7eXnJ2dlZzs7Oio2NtbTHxsZa2nOXL774wmrb3Pvg33rrLf3yyy8F7nv+/Pl5xlq+fHmefvHx8UpISMizn79btGiR+vTpI0nq0KGD0tPT9fnnn+fpV6ZMGUu4l6TFixerT58+Bc6mN2/ePE+NBYmPj5ebm5tl8ff3L7AvAAAA/o+Xl5dsbW2VlpZm1Z6WliYfH5/rbjt9+nRNnTpVn332merVq2dpz92uKGMCpYnwjpuya9cu7d+/X7Vr11ZWVpalfdSoUdq/f7/VEhoammf78PBwtWjRQuPGjStwH0888USesR555JE8/WrVqqW+ffsWOPuelJSkXbt2qXfv3pIkOzs79erVS4sWLcq3f79+/bR69WqlpqZq9erV6tevX4E1rlq1Kk+NBRkzZozS09Mty4kTJwrsCwAAgP9TtmxZNWrUyPKwOUmWh881a9aswO2mTZumyZMnKyEhIc/fpFWqVJGPj4/VmBkZGdq5c+d1xwRKm11pFwBjqlatmkwmk5KSkqzaAwMDJUnlypWzavfy8lK1atUKNfbUqVPVrFkzjRo1Kt/1bm5uhR5r4sSJqlGjRr5PBl20aJGuXr2qSpUqWdrMZrPs7e01d+5cubm5WfWvW7eugoOD1bt3b9WsWVN16tQpMJT7+/sXukZ7e3vZ29sXqi8AAACsxcTEKDIyUqGhoWrSpIlmzZqlixcvKjo6WpLUt29f+fn5KT4+XpL06quvKi4uTitWrFBAQIDlPvbcqyVNJpOGDx+ul19+WdWrV1eVKlU0btw4VapUSV26dCmtwwRuiJl35Kt8+fJq166d5s6dq4sXLxbr2E2aNNGjjz56w/vVC8Pf31+DBw/W2LFjlZ2dbWm/evWqli1bphkzZljNjh84cECVKlXSypUr8x2vX79+SkxMvO6sOwAAAG6fXr16afr06YqLi1P9+vW1f/9+JSQkWB44l5ycrJSUFEv/BQsW6PLly+revbt8fX0ty9+/9eiFF17QkCFDNHDgQDVu3FgXLlxQQkIC98XD0Jh5R4Hmz5+v+++/X6GhoZowYYLq1asnGxsbffvttzp8+LDVV6OdP38+z9M5HR0d8zwlPteUKVNUu3Zt2dnlPQUzMzPzjGVvby8PD498xxozZozefvttHTt2TL169ZIkrV+/XmfPntVTTz2VZ4a9W7duWrRokdV3x+caMGCAevToIXd393z3levMmTN5anR3d+cffAAAgBIwePBgDR48ON91iYmJVq+PHz9+w/FMJpMmTZpULA9SBm4XZt5RoKpVq2rfvn0KCwvTmDFjFBISotDQUL3xxhsaOXKkJk+ebOkbFxdn9cmmr6+vXnjhhQLHrlGjhvr166dLly7lWff222/nGSv3vvX8eHp6KjY21mqsRYsWKSwsLE9wl66F9927d+u7777Ls87Ozk5eXl75fqjwd2FhYXlqzO/SfQAAAAAoDiZzft+bBaDEZGRkyM3NTeO3H5WDs0tplwMAAGBIoxt4lXYJQInLzQbp6ekFXrWci5l3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZnV9oFAHermJDycnV1Le0yAAAAANwBmHkHAAAAAMDgCO8AAAAAABgc4R0AAAAAAIMjvAMAAAAAYHCEdwAAAAAADI7wDgAAAACAwRHeAQAAAAAwOMI7AAAAAAAGZ1faBQB3q5kHzsjB+XJplwEAAP7lRjfwKu0SABQDZt4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAHeJefPmKSAgQA4ODmratKl27dpVYN8ffvhB3bp1U0BAgEwmk2bNmpWnz/nz5zV8+HBVrlxZ5cqVU/PmzfXtt9+W4BEAdy/COwAAAHAXWLVqlWJiYjR+/Hjt3btXISEhCg8P1+nTp/Ptn5mZqcDAQE2dOlU+Pj759unfv782bdqk//znPzp48KDat2+vsLAwnTx5siQPBbgrEd5RKL///rueffZZ3XvvvbK3t5ePj4/Cw8P11VdfSZLlE9l/LlOnTrUaZ+nSpWrcuLEcHR3l4uKiVq1aaf369VZ9lixZInd393zrMJlMWrdunSTp+PHj+e7TZDLpm2++sYxlMpnUoUMHq3HOnTsnk8mkxMREq/Zt27bpoYceUvny5eXo6KhatWrp+eeft/wfUGJiYoH7TE1NLcpbCwAAcFvMnDlTAwYMUHR0tGrVqqWFCxfK0dFRixcvzrd/48aN9dprr+mxxx6Tvb19nvV//fWXPvjgA02bNk0tW7ZUtWrVNGHCBFWrVk0LFiwo6cMB7jqEdxRKt27dtG/fPi1dulQ//fSTPv74Y7Vu3Vpnzpyx9Jk0aZJSUlKsliFDhljWjxw5Uk8//bR69eql7777Trt27VKLFi3UuXNnzZ07t8i1bd68Oc9+GzVqZFlvZ2enzZs3a9u2bdcd580331RYWJh8fHz0wQcf6Mcff9TChQuVnp6uGTNmWPVNSkrKs8+KFSsW+RgAAABK0uXLl7Vnzx6FhYVZ2mxsbBQWFqYdO3YUacyrV68qOztbDg4OVu3lypXTl19+eUv1AsjLrrQLgPGdO3dOX3zxhRITE9WqVStJUuXKldWkSROrfi4uLgVeUvXNN99oxowZmjNnjlWgnzJlii5duqSYmBh17txZ/v7+N11f+fLlC9yvJDk5Oalnz54aPXq0du7cmW+f3377TUOHDtXQoUP1+uuvW9oDAgLUsmVLnTt3zqp/xYoVC7w64J+ysrKUlZVleZ2RkVGo7QAAAIrLH3/8oezsbHl7e1u1e3t76/Dhw0Ua08XFRc2aNdPkyZNVs2ZNeXt7a+XKldqxY4eqVatWHGUD+Btm3nFDzs7OcnZ21rp166xC6M1YuXKlnJ2d9fTTT+dZ9/zzz+vKlSv64IMPbrXUAk2YMEEHDx7UmjVr8l2/evVqXb58WS+88EK+6wsb1PMTHx8vNzc3y1KUDygAAACM6D//+Y/MZrP8/Pxkb2+vOXPmqHfv3rKxIWYAxY3/qnBDdnZ2WrJkiZYuXSp3d3fdf//9Gjt2rL777jurfrGxsZagn7t88cUXkqSffvpJVatWVdmyZfOMX6lSJbm6uuqnn34qUn3NmzfPs9/89jFs2DC9+OKLunr1ap71R44ckaurq3x9fQu1z3vuucdqf7Vr1y6w75gxY5Senm5ZTpw4UfiDAwAAKAZeXl6ytbVVWlqaVXtaWtp1r2C8kapVq+rzzz/XhQsXdOLECe3atUtXrlxRYGDgrZYM4B+4bB6F0q1bNz388MP64osv9M0332jjxo2aNm2a3nnnHUVFRUmSRo0aZfk5l5+fn+Vns9l83X3kF+wLY9WqVapZs+YN+8XGxurNN9/U4sWL1bNnT6t1ZrNZJpOp0Pv84osv5OLiYnldpkyZAvva29vn+5AXAACA26Vs2bJq1KiRtmzZoi5dukiScnJytGXLFg0ePPiWx3dycpKTk5POnj2r//3vf5o2bdotjwnAGuEdhebg4KB27dqpXbt2GjdunPr376/x48dbAruXl1eB9zdVr15dX375pS5fvpwnpJ86dUoZGRmqUaOGJMnV1VUXL15UTk6O1SVXufedu7m5WW3v7+9fqPuq3N3dNWbMGE2cOFERERFW62rUqKH09HSlpKQUava9SpUqt3QpPQAAwO0WExOjyMhIhYaGqkmTJpo1a5YuXryo6OhoSVLfvn3l5+en+Ph4Sdcecvfjjz9afj558qT2798vZ2dny99e//vf/2Q2mxUUFKSff/5Zo0aNUnBwsGVMAMWHy+ZRZLVq1dLFixcL1bd37966cOGC3nzzzTzrpk+fLgcHB/Xq1UuSFBQUpKtXr2r//v1W/fbu3StJlpBfFEOGDJGNjY1mz55t1d69e3eVLVu2wE+J//nAOgAAgDtNr169NH36dMXFxal+/frav3+/EhISLA+xS05OVkpKiqX/qVOn1KBBAzVo0EApKSmaPn26GjRooP79+1v6pKena9CgQQoODlbfvn3VokUL/e9//7vuVYkAioaZd9zQmTNn1KNHD/Xr10/16tWTi4uLdu/erWnTpqlz586WfufPn8/zXeeOjo5ydXVVs2bNNGzYMI0aNUqXL19Wly5ddOXKFf33v//VnDlztGTJEpUvX16SVLt2bbVv3179+vXTjBkzFBgYqKSkJA0fPly9evWyuhQ/t75/7tfd3T3P15ZI164emDhxogYNGmTV7u/vr9dff12DBw9WRkaG+vbtq4CAAP32229atmyZnJ2drb4u7vTp07p06ZLVGOXLl+f/qAAAgKENHjy4wMvkExMTrV4HBATc8LbHnj175rkdEUDJILzjhpydndW0aVO9/vrr+uWXX3TlyhX5+/trwIABGjt2rKVfXFyc4uLirLZ9+umntXDhQknSrFmzVK9ePc2fP18vvfSSLl26pLJly2rr1q1q2bKl1XarVq3S+PHj9fTTT+vUqVO655571LVrV40bNy5PfX//vtJcK1eu1GOPPZbv8URGRmrGjBmWy8ByPffcc6pRo4amT5+url276q+//lJAQIAiIiIUExNj1TcoKCjPuDt27NB9992X7z4BAAAA4FaYzDf6OA0oIcePH1erVq3UrFkzLV++XLa2tqVd0m2RkZEhNzc3jd9+VA7OLjfeAAAA4BaMbuBV2iUAKEBuNkhPT5erq+t1+3LPO0pNQECAEhMTFRwcnOf+dgAAAADA/+GyeZSqKlWqaMKECaVdBgAAAAAYGjPvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYnF1pFwDcrWJCysvV1bW0ywAAAABwB2DmHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAg7Mr7QKAu9XMA2fk4Hy5tMsAAAClYHQDr9IuAcAdhpl3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAEApmjdvngICAuTg4KCmTZtq165dBfb94Ycf1K1bNwUEBMhkMmnWrFl5+mRnZ2vcuHGqUqWKypUrp6pVq2ry5Mkym80leBQAShrhHShAVFSUunTpYvnZZDLJZDKpTJky8vb2Vrt27bR48WLl5OSUbqEAAOCOtWrVKsXExGj8+PHau3evQkJCFB4ertOnT+fbPzMzU4GBgZo6dap8fHzy7fPqq69qwYIFmjt3rg4dOqRXX31V06ZN0xtvvFGShwKghBHegULq0KGDUlJSdPz4cW3cuFFt2rTRsGHDFBERoatXr5Z2eQAA4A40c+ZMDRgwQNHR0apVq5YWLlwoR0dHLV68ON/+jRs31muvvabHHntM9vb2+fb5+uuv1blzZz388MMKCAhQ9+7d1b59++vO6AMwPsI7UEj29vby8fGRn5+fGjZsqLFjx+qjjz7Sxo0btWTJktIuDwAA3GEuX76sPXv2KCwszNJmY2OjsLAw7dixo8jjNm/eXFu2bNFPP/0kSTpw4IC+/PJLdezY8ZZrBlB67Eq7AOBO1rZtW4WEhGjt2rXq379/vn2ysrKUlZVleZ2RkXG7ygMAAAb2xx9/KDs7W97e3lbt3t7eOnz4cJHHHT16tDIyMhQcHCxbW1tlZ2drypQpeuKJJ261ZACliJl34BYFBwfr+PHjBa6Pj4+Xm5ubZfH39799xQEAgLvO+++/r+XLl2vFihXau3evli5dqunTp2vp0qWlXRqAW0B4B26R2WyWyWQqcP2YMWOUnp5uWU6cOHEbqwMAAEbl5eUlW1tbpaWlWbWnpaUV+DC6whg1apRGjx6txx57THXr1tWTTz6pESNGKD4+/lZLBlCKCO/ALTp06JCqVKlS4Hp7e3u5urpaLQAAAGXLllWjRo20ZcsWS1tOTo62bNmiZs2aFXnczMxM2dhY/5lva2vLN+QAdzjueQduwdatW3Xw4EGNGDGitEsBAAB3oJiYGEVGRio0NFRNmjTRrFmzdPHiRUVHR0uS+vbtKz8/P8us+eXLl/Xjjz9afj558qT2798vZ2dnVatWTZLUqVMnTZkyRffee69q166tffv2aebMmerXr1/pHCSAYkF4BwopKytLqampys7OVlpamhISEhQfH6+IiAj17du3tMsDAAB3oF69eun3339XXFycUlNTVb9+fSUkJFgeYpecnGw1i37q1Ck1aNDA8nr69OmaPn26WrVqpcTEREnSG2+8oXHjxum5557T6dOnValSJT399NOKi4u7rccGoHiZzGazubSLAIwoKipK586d07p16xQVFWV5yIudnZ08PDwUEhKixx9/XJGRkXkuTbuejIwMubm5afz2o3Jwdimp8gEAgIGNbuBV2iUAMIDcbJCenn7D22sJ78BtRngHAACEdwDSzYV3HlgHAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwODsSrsA4G4VE1Jerq6upV0GAAAAgDsAM+8AAAAAABhcsYX3c+fOFddQAAAAAADgb4oU3l999VWtWrXK8rpnz54qX768/Pz8dODAgWIrDgAAAAAAFDG8L1y4UP7+/pKkTZs2adOmTdq4caM6duyoUaNGFWuBAAAAAADc7Yr0wLrU1FRLeF+/fr169uyp9u3bKyAgQE2bNi3WAgEAAAAAuNsVaebdw8NDJ06ckCQlJCQoLCxMkmQ2m5WdnV181QEAAAAAgKLNvD/66KN6/PHHVb16dZ05c0YdO3aUJO3bt0/VqlUr1gIBAAAAALjbFSm8v/766woICNCJEyc0bdo0OTs7S5JSUlL03HPPFWuBAAAAAADc7Uxms9lc2kUAd5OMjAy5ubkpPT1drq6upV0OAAAAgFJyM9mgSDPvkvSf//xHb775po4ePaodO3aocuXKmjVrlqpUqaLOnTsXdVjgrjHzwBk5OF8u7TIA3AVGN/Aq7RIAAMAtKtID6xYsWKCYmBh17NhR586dszykzt3dXbNmzSrO+gAAAAAAuOsVKby/8cYbevvtt/Xiiy/K1tbW0h4aGqqDBw8WW3EAAAAAAKCI4f3YsWNq0KBBnnZ7e3tdvHjxlosCAAAAAAD/p0jhvUqVKtq/f3+e9oSEBNWsWfNWawIAAAAAAH9TpAfWxcTEaNCgQbp06ZLMZrN27dqllStXKj4+Xu+8805x1wgAAAAAwF2tSOG9f//+KleunF566SVlZmbq8ccfV6VKlTR79mw99thjxV0jAAAAAAB3tZsO71evXtWKFSsUHh6uJ554QpmZmbpw4YIqVqxYEvUBAAAAAHDXu+l73u3s7PTMM8/o0qVLkiRHR0eCOwAAAAAAJahID6xr0qSJ9u3bV9y1AAAAAACAfBTpnvfnnntOzz//vH777Tc1atRITk5OVuvr1atXLMUBAAAAAIAihvfch9INHTrU0mYymWQ2m2UymZSdnV081QEAAAAAgKKF92PHjhV3HQAAAAAAoABFuue9cuXK110AAIDxzJs3TwEBAXJwcFDTpk21a9euAvv+8MMP6tatmwICAmQymTRr1qxbHhMAABRdkWbely1bdt31ffv2LVIxAACgZKxatUoxMTFauHChmjZtqlmzZik8PFxJSUn5fmtMZmamAgMD1aNHD40YMaJYxgQAAEVXpJn3YcOGWS3PPfecoqKiNHDgQA0fPryYS4RRREVFyWQyyWQyqUyZMvL29la7du20ePFi5eTkWPrlztKYTCY5Ojqqbt26euedd6zGWrJkidzd3fPdj8lk0rp166zaPvjgA7Vt21YeHh4qV66cgoKC1K9fP+3bt0+JiYmW/RW0TJ48Wb6+vvrzzz+txj1w4IDs7e21fv16y75zFzc3N91///3aunVrvu/B35cOHTrcwjsLACVv5syZGjBggKKjo1WrVi0tXLhQjo6OWrx4cb79GzdurNdee02PPfaY7O3ti2VMAABQdEUK72fPnrVaLly4oKSkJLVo0UIrV64s7hphIB06dFBKSoqOHz+ujRs3qk2bNho2bJgiIiJ09epVS79JkyYpJSVF33//vfr06aMBAwZo48aNRdpnbGysevXqpfr16+vjjz9WUlKSVqxYocDAQI0ZM0bNmzdXSkqKZenZs6elztwlNjZW/v7+GjRokGXcK1euKDIyUn369FFERISl/d1331VKSoq++uoreXl5KSIiQkePHs3zHvx94bwHYGSXL1/Wnj17FBYWZmmzsbFRWFiYduzYYZgxAQBAwYp02Xx+qlevrqlTp6pPnz46fPhwcQ0Lg7G3t5ePj48kyc/PTw0bNtR9992nBx98UEuWLFH//v0lSS4uLpZ+sbGxmjZtmjZt2qSOHTve1P6++eYbTZs2TbNnz7b6doN7771XjRo1snzDQe6+JKlcuXLKysqyapOu3e7RoEEDrVmzRt27d9eUKVN07tw5vf7661b93N3d5ePjIx8fHy1YsEB+fn7atGmTnn766TzvAQDcCf744w9lZ2fL29vbqt3b27vI/59dEmMCAICCFVt4lyQ7OzudOnWqOIfEHaBt27YKCQnR2rVrLeE9V05Ojj788EOdPXtWZcuWvemxV65cKWdnZz333HP5rjeZTIUeKzg4WPHx8Xr22Wfl4uKi+Ph4JSQkyNXVtcBtypUrJ+naDFNRZWVlKSsry/I6IyOjyGMBAAAAuDsVKbx//PHHVq/NZrNSUlI0d+5c3X///cVSGO4swcHB+u677yyvY2Nj9dJLLykrK0tXr16Vp6dnnmBfGD/99JMCAwNlZ/d/p+rMmTMVFxdneX3y5Em5ubkVarxhw4bpo48+0kMPPaQhQ4aoTZs2BfbNzMzUSy+9JFtbW7Vq1crSvn79ejk7O1v1HTt2rMaOHZvvOPHx8Zo4cWKh6gOAkuDl5SVbW1ulpaVZtaelpRX5SqKSGBMAABSsSOG9S5cuVq9NJpMqVKigtm3basaMGcVRF+4wuZev5xo1apSioqKUkpKiUaNG6bnnnlO1atWKZV/9+vXTI488op07d6pPnz4ym82F3tZkMunFF19UYmKiXnrppXz79O7dW7a2tvrrr79UoUIFLVq0SPXq1bOsb9OmjRYsWGC1jaenZ4H7HDNmjGJiYiyvMzIy5O/vX+iaAeBWlS1bVo0aNdKWLVss/x+ek5OjLVu2aPDgwYYZEwAAFKxI4f3vTxYHJOnQoUOqUqWK5bWXl5eqVaumatWqafXq1apbt65CQ0NVq1YtSZKrq6suXryonJwc2dj833MTz507J0mWmfTq1avryy+/1JUrV1SmTBlJ1+5Jd3d312+//VakWnNn8f8+m/93r7/+usLCwuTm5qYKFSrkWe/k5HRTH0TY29sX+KRmALhdYmJiFBkZqdDQUDVp0kSzZs3SxYsXFR0dLena17z6+fkpPj5e0rXbhX788UfLzydPntT+/fvl7Oxs+TfwRmMCAIDiU6SnzU+aNEmZmZl52v/66y9NmjTplovCnWXr1q06ePCgunXrlu96f39/9erVS2PGjLG0BQUF6erVq9q/f79V371790qSatSoIenaLPiFCxc0f/78kik+Hz4+PqpWrVq+wR0A7lS9evXS9OnTFRcXp/r162v//v1KSEiwPHAuOTlZKSkplv6nTp1SgwYN1KBBA6WkpGj69Olq0KCB1S1QNxoTAAAUnyLNvE+cOFHPPPOMHB0drdozMzM1ceJEq/uR8e+SlZWl1NRUZWdnKy0tTQkJCYqPj1dERIT69u1b4HbDhg1TnTp1tHv3boWGhqp27dpq3769+vXrpxkzZigwMFBJSUkaPny4evXqJT8/P0lSs2bN9Pzzz+v555/Xr7/+qkcffVT+/v5KSUnRokWLZDKZrGbub4fc9+Dv7Ozs5OXldVvrAICbNXjw4AIvaU9MTLR6HRAQUKjbkq43JgAAKD5FCu//vL8514EDB6577y/ufAkJCfL19ZWdnZ08PDwUEhKiOXPmKDIy8rohulatWmrfvr3i4uK0YcMGSdKqVas0fvx4Pf300zp16pTuuecede3aVePGjbPadvr06WrSpIkWLFigxYsXKzMzU97e3mrZsqV27Nhx3afFl4Tc9+DvgoKC+GokAAAAACXGZL6Jp315eHjIZDIpPT1drq6uVgE+OztbFy5c0DPPPKN58+aVSLHAv0FGRobc3Nw0fvtROTi7lHY5AO4CoxtwZRAAAEaUmw1yM/b13NTM+6xZs2Q2m9WvXz9NnDjR6uu5ypYtq4CAADVr1qxoVQMAAAAAgHzdVHiPjIyUJFWpUkXNmze3PP0bAAAAAACUnCLd896qVSvLz5cuXdLly5et1t/ue5ABAAAAAPg3K9JjujMzMzV48GBVrFhRTk5O8vDwsFoAAAAAAEDxKVJ4HzVqlLZu3aoFCxbI3t5e77zzjiZOnKhKlSpp2bJlxV0jAAAAAAB3tSJdNv/JJ59o2bJlat26taKjo/XAAw+oWrVqqly5spYvX64nnniiuOsEAAAAAOCuVaSZ9z///FOBgYGSrt3f/ueff0qSWrRooe3btxdfdQAAAAAAoGjhPTAwUMeOHZMkBQcH6/3335d0bUbe3d292IoDAAAAAABFDO/R0dE6cOCAJGn06NGaN2+eHBwcNGLECI0aNapYCwQAAAAA4G5XpHveR4wYYfk5LCxMhw8f1p49e1StWjXVq1ev2IoDAAAAAABFDO9/d+nSJVWuXFmVK1cujnoAAAAAAMA/FOmy+ezsbE2ePFl+fn5ydnbW0aNHJUnjxo3TokWLirVAAAAAAADudkWaeZ8yZYqWLl2qadOmacCAAZb2OnXqaNasWXrqqaeKrUDg3yompLxcXV1LuwwAAAAAd4AizbwvW7ZMb731lp544gnZ2tpa2kNCQnT48OFiKw4AAAAAABQxvJ88eVLVqlXL056Tk6MrV67cclEAAAAAAOD/FCm816pVS1988UWe9jVr1qhBgwa3XBQAAAAAAPg/RbrnPS4uTpGRkTp58qRycnK0du1aJSUladmyZVq/fn1x1wgAAAAAwF3tpmbejx49KrPZrM6dO+uTTz7R5s2b5eTkpLi4OB06dEiffPKJ2rVrV1K1AgAAAABwV7qpmffq1asrJSVFFStW1AMPPCBPT08dPHhQ3t7eJVUfAAAAAAB3vZuaeTebzVavN27cqIsXLxZrQQAAAAAAwFqRHliX659hHgAAAAAAFL+bumzeZDLJZDLlaQNw82YeOCMH58ulXYYhjW7gVdolAAAAAIZyU+HdbDYrKipK9vb2kqRLly7pmWeekZOTk1W/tWvXFl+FAAAAAADc5W4qvEdGRlq97tOnT7EWAwAAAAAA8rqp8P7uu++WVB0AAAAAAKAAt/TAOgAAAAAAUPII7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHYBhzZs3TwEBAXJwcFDTpk21a9eu6/ZfvXq1goOD5eDgoLp162rDhg2WdVeuXFFsbKzq1q0rJycnVapUSX379tWpU6dK+jAAAACAW0Z4Rx5RUVHq0qXLdfsEBARo1qxZhR7z+PHjMplM2r9//y3VhrvHqlWrFBMTo/Hjx2vv3r0KCQlReHi4Tp8+nW//r7/+Wr1799ZTTz2lffv2qUuXLurSpYu+//57SVJmZqb27t2rcePGae/evVq7dq2SkpL0yCOP3M7DAgAAAIqE8F4KoqKiZDKZZDKZVKZMGXl7e6tdu3ZavHixcnJySru8Qvn22281cODA0i5DkpSYmCiTyaRz587d1HZ8oGBsM2fO1IABAxQdHa1atWpp4cKFcnR01OLFi/PtP3v2bHXo0EGjRo1SzZo1NXnyZDVs2FBz586VJLm5uWnTpk3q2bOngoKCdN9992nu3Lnas2ePkpOTb+ehAQAAADeN8F5KOnTooJSUFB0/flwbN25UmzZtNGzYMEVEROjq1av5bnPlypXbXGXBKlSoIEdHx9IuA/9Sly9f1p49exQWFmZps7GxUVhYmHbs2JHvNjt27LDqL0nh4eEF9pek9PR0mUwmubu7F0vdAAAAQEkhvJcSe3t7+fj4yM/PTw0bNtTYsWP10UcfaePGjVqyZIkkyWQyacGCBXrkkUfk5OSkKVOmaMmSJXmCxrp162QymazaXn75ZVWsWFEuLi7q37+/Ro8erfr1699UjdOnT5evr6/Kly+vQYMGWX148M/L5g8fPqwWLVrIwcFBtWrV0ubNm2UymbRu3TqrMY8ePao2bdrI0dFRISEh1w1Wf/frr7+qU6dO8vDwkJOTk2rXrq0NGzbo+PHjatOmjSTJw8NDJpNJUVFRkqSEhAS1aNFC7u7uKl++vCIiIvTLL79YxqxSpYokqUGDBjKZTGrdurUkqXXr1ho+fLjV/rt06WIZV5Lmz5+v6tWry8HBQd7e3urevXuBtWdlZSkjI8NqwfX98ccfys7Olre3t1W7t7e3UlNT890mNTX1pvpfunRJsbGx6t27t1xdXYuncAAAAKCEEN4NpG3btgoJCdHatWstbRMmTFDXrl118OBB9evXr1DjLF++XFOmTNGrr76qPXv26N5779WCBQtuqpZt27bpl19+0bZt27R06VItWbLE8qHCP2VnZ6tLly5ydHTUzp079dZbb+nFF1/Mt++LL76okSNHav/+/apRo4Z69+5d4JUGfzdo0CBlZWVp+/btOnjwoF599VU5OzvL399fH3zwgSQpKSlJKSkpmj17tiTp4sWLiomJ0e7du7VlyxbZ2Nioa9eullsTch9+tnnzZqWkpFi979eze/duDR06VJMmTVJSUpISEhLUsmXLAvvHx8fLzc3Nsvj7+xdqPyg5V65cUc+ePWU2m2/6vw0AAACgNNiVdgGwFhwcrO+++87y+vHHH1d0dPRNjfHGG2/oqaeesmwXFxenzz77TBcuXCj0GB4eHpo7d65sbW0VHByshx9+WFu2bNGAAQPy9N20aZN++eUXJSYmysfHR5I0ZcoUtWvXLk/fkSNH6uGHH5YkTZw4UbVr19bPP/+s4ODg69aTnJysbt26qW7dupKkwMBAyzpPT09JUsWKFa2uSujWrZvVGIsXL1aFChX0448/qk6dOqpQoYIkqXz58pa6CyM5OVlOTk6KiIiQi4uLKleurAYNGhTYf8yYMYqJibG8zsjIIMDfgJeXl2xtbZWWlmbVnpaWVuDvysfHp1D9c4P7r7/+qq1btzLrDgAAgDsCM+8GYzabrS6BDw0NvekxkpKS1KRJE6u2f76+kdq1a8vW1tby2tfXt8CnfCclJcnf398qJBW0v3r16lmNKanAcf9u6NChevnll3X//fdr/PjxVh9wFOTIkSPq3bu3AgMD5erqqoCAAEm65YeTtWvXTpUrV1ZgYKCefPJJLV++XJmZmQX2t7e3l6urq9WC6ytbtqwaNWqkLVu2WNpycnK0ZcsWNWvWLN9tmjVrZtVfuvbB0t/75wb3I0eOaPPmzSpfvnzJHAAAAABQzAjvBnPo0CHLvdiS5OTkZLXexsZGZrPZqq0kHmRXpkwZq9cmk6lYnoT/93FzP6QozLj9+/fX0aNH9eSTT+rgwYMKDQ3VG2+8cd1tOnXqpD///FNvv/22du7cqZ07d0q69jC067nRe+zi4qK9e/dq5cqV8vX1VVxcnEJCQm76afe4vpiYGL399ttaunSpDh06pGeffVYXL160XFHSt29fjRkzxtJ/2LBhSkhI0IwZM3T48GFNmDBBu3fv1uDBgyVd+x12795du3fv1vLly5Wdna3U1FSlpqbe8JwAAAAAShvh3UC2bt2qgwcP5rnc++8qVKig8+fP6+LFi5a2f37VWVBQkL799lurtn++Lk5BQUE6ceKE1SXLJbE/f39/PfPMM1q7dq2ef/55vf3225KuzdJK1+69z3XmzBklJSXppZde0oMPPqiaNWvq7NmzVuPlt5107T1OSUmxvM7OzrZ8V3guOzs7hYWFadq0afruu+90/Phxbd26tfgOFurVq5emT5+uuLg41a9fX/v371dCQoLloXTJyclWv6fmzZtrxYoVeuuttxQSEqI1a9Zo3bp1qlOnjiTp5MmT+vjjj/Xbb7+pfv368vX1tSxff/11qRwjAAAAUFjc815KsrKylJqaquzsbKWlpSkhIUHx8fGKiIhQ3759C9yuadOmcnR01NixYzV06FDt3Lkzz4PkhgwZogEDBig0NFTNmzfXqlWr9N1331ndJ16c2rVrp6pVqyoyMlLTpk3T+fPn9dJLL0lSnqfgF9Xw4cPVsWNH1ahRQ2fPntW2bdtUs2ZNSVLlypVlMpm0fv16PfTQQypXrpw8PDxUvnx5vfXWW/L19VVycrJGjx5tNWbFihVVrlw5JSQk6J577pGDg4Pc3NzUtm1bxcTE6NNPP1XVqlU1c+ZMq1n19evX6+jRo2rZsqU8PDy0YcMG5eTkKCgoqFiOFf9n8ODBlpnzf0pMTMzT1qNHD/Xo0SPf/gEBAXmuqAAAAADuFMy8l5KEhAT5+voqICBAHTp00LZt2zRnzhx99NFHVvea/5Onp6f++9//asOGDapbt65WrlypCRMmWPV54oknNGbMGI0cOVINGzbUsWPHFBUVJQcHhxI5FltbW61bt04XLlxQ48aN1b9/f8vT5otrn9nZ2Ro0aJBq1qypDh06qEaNGpo/f74kyc/PTxMnTtTo0aPl7e2twYMHy8bGRu+995727NmjOnXqaMSIEXrttdesxrSzs9OcOXP05ptvqlKlSurcubMkqV+/foqMjFTfvn3VqlUrBQYGWr6OTpLc3d21du1atW3bVjVr1tTChQu1cuVK1a5du1iOFQAAAAD+yWRmKuqu0K5dO/n4+Og///nPbdnfV199pRYtWujnn39W1apVb8s+7xQZGRlyc3PT+O1H5eDsUtrlGNLoBl6lXQIAAABQ4nKzQXp6+g0fbM1l8/9CmZmZWrhwocLDw2Vra6uVK1dq8+bN2rRpU4nt88MPP5Szs7OqV6+un3/+WcOGDdP9999PcAcAAACAYsBl8/9CJpNJGzZsUMuWLdWoUSN98skn+uCDDxQWFiZJcnZ2LnD54osvirTP8+fPa9CgQQoODlZUVJQaN26sjz76qNDbd+zYscCaXnnllSLVBAAAAAD/Flw2fxf6+eefC1zn5+encuXK3cZqrjl58qT++uuvfNd5enrK09PzNldUcrhs/sa4bB4AAAB3Ay6bx3VVq1attEvIw8/Pr7RLAAAAAADD4rJ5AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcHalXQBwt4oJKS9XV9fSLgMAAADAHYCZdwAAAAAADI7wDgAAAACAwRHeAQAAAAAwOMI7AAAAAAAGR3gHAAAAAMDgCO8AAAAAABgc4R0AAAAAAIMjvAMAAAAAYHB2pV0AcLeaeeCMHJwvl3YZt83oBl6lXQIAAABwx2LmHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjuA227evHkKCAiQg4ODmjZtql27dl23/+rVqxUcHCwHBwfVrVtXGzZssKy7cuWKYmNjVbduXTk5OalSpUrq27evTp06VdKHAQAAANw2hHcoKipKJpNJJpNJZcqUkbe3t9q1a6fFixcrJyentMtTZmamxowZo6pVq8rBwUEVKlRQq1at9NFHH1n6BAQEaNasWTc9duvWrTV8+PDiKxY3tGrVKsXExGj8+PHau3evQkJCFB4ertOnT+fb/+uvv1bv3r311FNPad++ferSpYu6dOmi77//XtK182Pv3r0aN26c9u7dq7Vr1yopKUmPPPLI7TwsAAAAoEQR3iFJ6tChg1JSUnT8+HFt3LhRbdq00bBhwxQREaGrV6/mu82VK1duS23PPPOM1q5dqzfeeEOHDx9WQkKCunfvrjNnztyW/aN4zZw5UwMGDFB0dLRq1aqlhQsXytHRUYsXL863/+zZs9WhQweNGjVKNWvW1OTJk9WwYUPNnTtXkuTm5qZNmzapZ8+eCgoK0n333ae5c+dqz549Sk5Ovp2HBgAAAJQYwjskSfb29vLx8ZGfn58aNmyosWPH6qOPPtLGjRu1ZMkSSZLJZNKCBQv0yCOPyMnJSVOmTNGSJUvk7u5uNda6detkMpms2l5++WVVrFhRLi4u6t+/v0aPHq369esXqraPP/5YY8eO1UMPPaSAgAA1atRIQ4YMUb9+/SRdmz3/9ddfNWLECMsVBJJ05swZ9e7dW35+fnJ0dFTdunW1cuVKy7hRUVH6/PPPNXv2bMt2x48fL9QxHThwQG3atJGLi4tcXV3VqFEj7d69u1DHcze7fPmy9uzZo7CwMEubjY2NwsLCtGPHjny32bFjh1V/SQoPDy+wvySlp6fLZDLl+T0CAAAAdyrCOwrUtm1bhYSEaO3atZa2CRMmqGvXrjp48KAlPN/I8uXLNWXKFL366qvas2eP7r33Xi1YsKDQdfj4+GjDhg06f/58vuvXrl2re+65R5MmTVJKSopSUlIkSZcuXVKjRo306aef6vvvv9fAgQP15JNPWu6vnj17tpo1a6YBAwZYtvP39y9UTU888YTuueceffvtt9qzZ49Gjx6tMmXK5Ns3KytLGRkZVsvd6o8//lB2dra8vb2t2r29vZWamprvNqmpqTfV/9KlS4qNjVXv3r3l6upaPIUDAAAApcyutAuAsQUHB+u7776zvH788ccVHR19U2O88cYbeuqppyzbxcXF6bPPPtOFCxcKtf1bb72lJ554QuXLl1dISIhatGih7t276/7775ckeXp6ytbWVi4uLvLx8bFs5+fnp5EjR1peDxkyRP/73//0/vvvq0mTJnJzc1PZsmXl6OhotV1hJCcna9SoUQoODpYkVa9evcC+8fHxmjhx4k2Nj6K5cuWKevbsKbPZfFMfEAEAAABGx8w7rstsNltdLh4aGnrTYyQlJalJkyZWbf98fT0tW7bU0aNHtWXLFnXv3l0//PCDHnjgAU2ePPm622VnZ2vy5MmqW7euPD095ezsrP/973/Fch90TEyM+vfvr7CwME2dOlW//PJLgX3HjBmj9PR0y3LixIlb3v+dysvLS7a2tkpLS7NqT0tLK/ADFB8fn0L1zw3uv/76qzZt2sSsOwAAAP5VCO+4rkOHDqlKlSqW105OTlbrbWxsZDabrdpK4kF2ZcqU0QMPPKDY2Fh99tlnmjRpkiZPnqzLly8XuM1rr72m2bNnKzY2Vtu2bdP+/fsVHh5+3W2kwh3ThAkT9MMPP+jhhx/W1q1bVatWLX344Yf5jmdvby9XV1er5W5VtmxZNWrUSFu2bLG05eTkaMuWLWrWrFm+2zRr1syqvyRt2rTJqn9ucD9y5Ig2b96s8uXLl8wBAAAAAKWE8I4Cbd26VQcPHlS3bt0K7FOhQgWdP39eFy9etLTt37/fqk9QUJC+/fZbq7Z/vr5ZtWrV0tWrV3Xp0iVJ10Jhdna2VZ+vvvpKnTt3Vp8+fRQSEqLAwED99NNPVn3y264wxyRJNWrU0IgRI/TZZ5/p0Ucf1bvvvntLx3S3iImJ0dtvv62lS5fq0KFDevbZZ3Xx4kXLbRV9+/bVmDFjLP2HDRumhIQEzZgxQ4cPH9aECRO0e/duDR48WNK14N69e3ft3r1by5cvV3Z2tlJTU5WamnrDD2oAAACAOwX3vEPStYeqpaamKjs7W2lpaUpISFB8fLwiIiLUt2/fArdr2rSpHB0dNXbsWA0dOlQ7d+60PJ0+15AhQzRgwACFhoaqefPmWrVqlb777jsFBgYWqrbWrVurd+/eCg0NVfny5fXjjz9q7NixatOmjWUWOyAgQNu3b9djjz0me3t7eXl5qXr16lqzZo2+/vpreXh4aObMmUpLS1OtWrUsYwcEBGjnzp06fvy4nJ2d5enpecNj+uuvvzRq1Ch1795dVapU0W+//aZvv/32uh9y4P/06tVLv//+u+Li4pSamqr69esrISHB8lC65ORk2dj83+eKzZs314oVK/TSSy9p7Nixql69utatW6c6depIkk6ePKmPP/5YkvJ8g8G2bdvUunXr23JcAAAAQEkymf95fTDuOlFRUVq6dKkkyc7OTh4eHgoJCdHjjz+uyMhIS5AymUz68MMP1aVLF6vt161bp1GjRunkyZN68MEH9cgjj2jgwIFWl55PnjxZc+bM0aVLl9SzZ085Oztr165d1/26r1zx8fH65JNPlJSUpMzMTFWqVEkRERGKi4uzXB79zTff6Omnn1ZSUpKysrJkNpv1559/ql+/ftqyZYscHR01cOBAJScnKz09XevWrZMk/fTTT4qMjNSBAwf0119/6dixYwoICLjuMV2+fFmRkZH66quvlJaWJi8vLz366KN67bXX5ODgcMPjycjIkJubm8ZvPyoHZ5fC/Ir+FUY38CrtEgAAAABDyc0G6enpN7y9lvCOUtGuXTv5+PjoP//5T2mXctsR3gEAAABINxfeuWweJS4zM1MLFy5UeHi4bG1ttXLlSm3evFmbNm0q7dIAAAAA4I5AeEeJM5lM2rBhg6ZMmaJLly4pKChIH3zwgcLCwiRJzs7OBW67ceNGPfDAA7erVAAAAAAwJMI7Sly5cuW0efPmAtfn9yT3XH5+fiVQEQAAAADcWQjvKHXVqlUr7RIAAAAAwND4nncAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwdqVdAHC3igkpL1dX19IuAwAAAMAdgJl3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMzq60CwDuVjMPnJGD8+XSLqNYjW7gVdolAAAAAP9KzLwDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABndHhHeTyaR169aVdhm3hdls1sCBA+Xp6SmTyaT9+/dft3/r1q01fPjw6/a52fcvMTFRJpNJ586dK/Q2wD/NmzdPAQEBcnBwUNOmTbVr167r9l+9erWCg4Pl4OCgunXrasOGDZZ1V65cUWxsrOrWrSsnJydVqlRJffv21alTp0r6MAAAAABDKNXwHhUVJZPJJJPJpDJlysjb21vt2rXT4sWLlZOTY+mXkpKijh07lmKlt09CQoKWLFmi9evXKyUlRXXq1LnlMY34/gUEBGjWrFnFMlZRP2w4fvx4oT4gwc1btWqVYmJiNH78eO3du1chISEKDw/X6dOn8+3/9ddfq3fv3nrqqae0b98+denSRV26dNH3338vScrMzNTevXs1btw47d27V2vXrlVSUpIeeeSR23lYAAAAQKkp9Zn3Dh06KCUlRcePH9fGjRvVpk0bDRs2TBEREbp69aokycfHR/b29qVc6e3xyy+/yNfXV82bN5ePj4/s7Oxuecy76f2DMcycOVMDBgxQdHS0atWqpYULF8rR0VGLFy/Ot//s2bPVoUMHjRo1SjVr1tTkyZPVsGFDzZ07V5Lk5uamTZs2qWfPngoKCtJ9992nuXPnas+ePUpOTr6dhwYAAACUilIP7/b29vLx8ZGfn58aNmyosWPH6qOPPtLGjRu1ZMkSSdaXfV++fFmDBw+Wr6+vHBwcVLlyZcXHx1vGO3funPr3768KFSrI1dVVbdu21YEDByzrf/nlF3Xu3Fne3t5ydnZW48aNtXnzZqua5s+fr+rVq8vBwUHe3t7q3r27ZV1OTo7i4+NVpUoVlStXTiEhIVqzZk2hj/fzzz9XkyZNZG9vL19fX40ePdryIUVUVJSGDBmi5ORkmUwmBQQEFGrMnJwcvfDCC/L09JSPj48mTJhgtf6fl81//fXXql+/vhwcHBQaGqp169blOwO9Z88ehYaGytHRUc2bN1dSUpLV+o8++kgNGzaUg4ODAgMDNXHiRMuxmM1mTZgwQffee6/s7e1VqVIlDR06VNK1S/1//fVXjRgxwnLlxY38+uuv6tSpkzw8POTk5KTatWtrw4YNOn78uNq0aSNJ8vDwkMlkUlRUlKRrVzG0aNFC7u7uKl++vCIiIvTLL79YxqxSpYokqUGDBjKZTGrdurWlvn/eitClSxfLuNL1z5G73eXLl7Vnzx6FhYVZ2mxsbBQWFqYdO3bku82OHTus+ktSeHh4gf0lKT09XSaTSe7u7sVSNwAAAGBkpR7e89O2bVuFhIRo7dq1edbNmTNHH3/8sd5//30lJSVp+fLlViG3R48eOn36tDZu3Kg9e/aoYcOGevDBB/Xnn39Kki5cuKCHHnpIW7Zs0b59+9ShQwd16tTJMnu3e/duDR06VJMmTVJSUpISEhLUsmVLy/jx8fFatmyZFi5cqB9++EEjRoxQnz599Pnnn9/wuE6ePKmHHnpIjRs31oEDB7RgwQItWrRIL7/8sqRrs4+TJk3SPffco5SUFH377beFer+WLl0qJycn7dy5U9OmTdOkSZO0adOmfPtmZGSoU6dOqlu3rvbu3avJkycrNjY2374vvviiZsyYod27d8vOzk79+vWzrPviiy/Ut29fDRs2TD/++KPefPNNLVmyRFOmTJEkffDBB3r99df15ptv6siRI1q3bp3q1q0rSVq7dq3uueceTZo0SSkpKUpJSbnhMQ4aNEhZWVnavn27Dh48qFdffVXOzs7y9/fXBx98IElKSkpSSkqKZs+eLUm6ePGiYmJitHv3bm3ZskU2Njbq2rWr5ZaM3HuwN2/erJSUlHzPt/zc6Bz5p6ysLGVkZFgt/2Z//PGHsrOz5e3tbdXu7e2t1NTUfLdJTU29qf6XLl1SbGysevfuLVdX1+IpHAAAADCwW78mu4QEBwfru+++y9OenJys6tWrq0WLFjKZTKpcubJl3Zdffqldu3bp9OnTlsvEp0+frnXr1mnNmjUaOHCgQkJCFBISYtlm8uTJ+vDDD/Xxxx9r8ODBSk5OlpOTkyIiIuTi4qLKlSurQYMGkq6FsFdeeUWbN29Ws2bNJEmBgYH68ssv9eabb6pVq1bXPab58+fL399fc+fOlclkUnBwsE6dOqXY2FjFxcXJzc1NLi4usrW1lY+PT6Hfq3r16mn8+PGSpOrVq2vu3LnasmWL2rVrl6fvihUrZDKZ9Pbbb8vBwUG1atXSyZMnNWDAgDx9p0yZYjmm0aNH6+GHH9alS5fk4OCgiRMnavTo0YqMjLS8D5MnT9YLL7yg8ePHKzk5WT4+PgoLC1OZMmV07733qkmTJpIkT09P2draysXFpdDHmZycrG7dulk+AAgMDLSs8/T0lCRVrFjRaha2W7duVmMsXrxYFSpU0I8//qg6deqoQoUKkqTy5cvf1Pt9vXMkP/Hx8Zo4cWKhx8f1XblyRT179pTZbNaCBQtKuxwAAADgtjDkzLt07bLr/C6njoqK0v79+xUUFKShQ4fqs88+s6w7cOCALly4oPLly8vZ2dmyHDt2zHK59IULFzRy5EjVrFlT7u7ucnZ21qFDhywz7+3atVPlypUVGBioJ598UsuXL1dmZqYk6eeff1ZmZqbatWtnNf6yZcusLscuyKFDh9SsWTOr47r//vt14cIF/fbbb0V+r+rVq2f12tfXt8AHgyUlJalevXpycHCwtOWG6uuN6+vrK0mWcQ8cOKBJkyZZvQ8DBgxQSkqKMjMz1aNHD/31118KDAzUgAED9OGHH1ouqS+KoUOH6uWXX9b999+v8ePH5/vBzj8dOXJEvXv3VmBgoFxdXS1XaNzqPdLXO0fyM2bMGKWnp1uWEydO3NL+jc7Ly0u2trZKS0uzak9LSyvwQxIfH59C9c8N7r/++qs2bdrErDsAAADuGoYN74cOHbLck/x3DRs21LFjxzR58mT99ddf6tmzp+V+4wsXLsjX11f79++3WpKSkjRq1ChJ0siRI/Xhhx/qlVde0RdffKH9+/erbt26unz5siTJxcVFe/fu1cqVK+Xr66u4uDiFhITo3LlzunDhgiTp008/tRr/xx9/vKn73otbmTJlrF6bTCarp/UXx7i5HzjkjnvhwgVNnDjR6n04ePCgjhw5IgcHB/n7+yspKUnz589XuXLl9Nxzz6lly5a6cuVKkWrp37+/jh49qieffFIHDx5UaGio3njjjetu06lTJ/355596++23tXPnTu3cuVOSLL/rgtjY2MhsNlu1/b3u650j+bG3t5erq6vV8m9WtmxZNWrUSFu2bLG05eTkaMuWLZYrVv6pWbNmVv0ladOmTVb9c4P7kSNHtHnzZpUvX75kDgAAAAAwIENeNr9161YdPHhQI0aMyHe9q6urevXqpV69eql79+7q0KGD/vzzTzVs2FCpqamys7Mr8GFvX331laKiotS1a1dJ10Lo8ePHrfrY2dkpLCxMYWFhGj9+vNzd3bV161a1a9dO9vb2Sk5OvuEl8vmpWbOmPvjgA6urCr766iu5uLjonnvuuenxiiIoKEj//e9/lZWVZbm1oLD31v9dw4YNlZSUpGrVqhXYp1y5curUqZM6deqkQYMGKTg4WAcPHlTDhg1VtmxZZWdn39Q+/f399cwzz+iZZ57RmDFj9Pbbb2vIkCEqW7asJFmNd+bMGSUlJentt9/WAw88IOnabRV/l992klShQgWr+/Czs7P1/fffWx6MJxV8jjz66KM3dUz/VjExMYqMjFRoaKiaNGmiWbNm6eLFi4qOjpYk9e3bV35+fpaHTQ4bNkytWrXSjBkz9PDDD+u9997T7t279dZbb0m6Fty7d++uvXv3av369crOzrbcD+/p6Wn5XQIAAAD/VqUe3rOyspSamqrs7GylpaUpISFB8fHxioiIUN++ffP0nzlzpnx9fdWgQQPZ2Nho9erV8vHxkbu7u8LCwtSsWTN16dJF06ZNU40aNXTq1Cl9+umn6tq1q0JDQ1W9enWtXbtWnTp1kslk0rhx46xmqdevX6+jR4+qZcuW8vDw0IYNG5STk6OgoCC5uLho5MiRGjFihHJyctSiRQulp6frq6++kqurq+X+74I899xzmjVrloYMGaLBgwcrKSlJ48ePV0xMjGxsbs9FEI8//rhefPFFDRw4UKNHj1ZycrKmT58uSYV66nuuuLg4RURE6N5771X37t1lY2OjAwcO6Pvvv9fLL7+sJUuWKDs7W02bNpWjo6P++9//qly5cpZnFAQEBGj79u167LHHZG9vLy8vr+vub/jw4erYsaNq1Kihs2fPatu2bapZs6YkqXLlyjKZTFq/fr0eeughlStXTh4eHipfvrzeeust+fr6Kjk5WaNHj7Yas2LFiipXrpwSEhJ0zz33yMHBQW5ubmrbtq1iYmL06aefqmrVqpo5c6bVrPr1zhFc06tXL/3++++Ki4tTamqq6tevr4SEBMtD6ZKTk63O+ebNm2vFihV66aWXNHbsWFWvXl3r1q1TnTp1JF172OPHH38sSapfv77VvrZt22b5pgAAAADg36rUw3tCQoJ8fX1lZ2cnDw8PhYSEaM6cOYqMjMw30Lq4uGjatGk6cuSIbG1t1bhxY23YsMHSd8OGDXrxxRcVHR2t33//XT4+PmrZsqUlNMycOVP9+vVT8+bN5eXlpdjYWKunf7u7u2vt2rWaMGGCLl26pOrVq2vlypWqXbu2pGsPuKtQoYLi4+N19OhRubu7W77i7kb8/Py0YcMGjRo1SiEhIfL09NRTTz2ll156qTjeykJxdXXVJ598omeffVb169dX3bp1FRcXp8cff9zqPvgbCQ8P1/r16zVp0iS9+uqrKlOmjIKDg9W/f39J197HqVOnKiYmRtnZ2apbt64++eQTy6XOkyZN0tNPP62qVasqKysrz2Xq/5Sdna1Bgwbpt99+k6urqzp06KDXX39d0rX3NfcBetHR0erbt6+WLFmi9957T0OHDlWdOnUUFBSkOXPmWIU8Ozs7zZkzR5MmTVJcXJweeOABJSYmql+/fjpw4ID69u0rOzs7jRgxwmrW/UbnCK4ZPHiwBg8enO+6xMTEPG09evRQjx498u0fEBBww3MEAAAA+DczmfmL+K63fPlyRUdHKz09XeXKlSvtcv71MjIy5ObmpvHbj8rB2aW0yylWoxtc/woKAAAAAP8nNxukp6ff8NlYpT7zjttv2bJlCgwMlJ+fnw4cOKDY2Fj17NmT4A4AAAAABmXYp83fiZ555hmrr077+/LMM8/c9HjJyckFjufs7FzkrzxLTU1Vnz59VLNmTY0YMUI9evSwPBistHTs2LHA43zllVdKtTYAAAAAKG1cNl+MTp8+bXX//N+5urqqYsWKNzXe1atX8zwJ/+8CAgJkZ/fvuHji5MmT+uuvv/Jd5+npKU9Pz9tcUcnhsnkAAAAAEpfNl5qKFSvedEC/Hjs7u+t+Fdu/iZ+fX2mXAAAAAACGxWXzAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4OxKuwDgbhUTUl6urq6lXQYAAACAOwAz7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGJxdaRcA3K1mHjgjB+fLpV1GsRrdwKu0SwAAAAD+lZh5BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAAAAAAAyO8A4AAAAAgMER3gEAAAAAMDjCOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDAAAAAGBwhHcAxW7evHkKCAiQg4ODmjZtql27dl23/+rVqxUcHCwHBwfVrVtXGzZssKy7cuWKYmNjVbduXTk5OalSpUrq27evTp06VdKHAQAAABgG4R1AsVq1apViYmI0fvx47d27VyEhIQoPD9fp06fz7f/111+rd+/eeuqpp7Rv3z516dJFXbp00ffffy9JyszM1N69ezVu3Djt3btXa9euVVJSkh555JHbeVgAAABAqSK8w0pUVJRMJpNMJpPKlCkjb29vtWvXTosXL1ZOTo6lX0BAgKWfo6Oj6tatq3feecdqrCVLlsjd3T3f/ZhMJq1bt86q7YMPPlDbtm3l4eGhcuXKKSgoSP369dO+ffusxjSZTOrQoYPVtufOnZPJZFJiYmKefT399NOytbXV6tWr86ybMGFCvuNJ0muvvSaTyaTWrVvn6f/PJTg4ON/jvBvNnDlTAwYMUHR0tGrVqqWFCxfK0dFRixcvzrf/7Nmz1aFDB40aNUo1a9bU5MmT1bBhQ82dO1eS5Obmpk2bNqlnz54KCgrSfffdp7lz52rPnj1KTk6+nYcGAAAAlBrCO/Lo0KGDUlJSdPz4cW3cuFFt2rTRsGHDFBERoatXr1r6TZo0SSkpKfr+++/Vp08fDRgwQBs3bizSPmNjY9WrVy/Vr19fH3/8sZKSkrRixQoFBgZqzJgxVn3t7Oy0efNmbdu27YbjZmZm6r333tMLL7xQYHj09fXVtm3b9Ntvv1m1L168WPfee2+e/rVr11ZKSorV8uWXX97E0f57Xb58WXv27FFYWJilzcbGRmFhYdqxY0e+2+zYscOqvySFh4cX2F+S0tPTZTKZCvxwCAAAAPi3sSvtAmA89vb28vHxkST5+fmpYcOGuu+++/Tggw9qyZIl6t+/vyTJxcXF0i82NlbTpk3Tpk2b1LFjx5va3zfffKNp06Zp9uzZGjp0qKX93nvvVaNGjWQ2m636Ozk5qWfPnho9erR27tx53bFXr16tWrVqafTo0apUqZJOnDghf39/qz4VK1ZUo0aNtHTpUr344ouSrl3K/ccff6hHjx768ccfrfrb2dlZjhvW/vjjD2VnZ8vb29uq3dvbW4cPH853m9TU1Hz7p6am5tv/0qVLio2NVe/eveXq6lo8hQMAAAAGx8w7CqVt27YKCQnR2rVr86zLycnRBx98oLNnz6ps2bI3PfbKlSvl7Oys5557Lt/1JpMpT9uECRN08OBBrVmz5rpjL1q0SH369JGbm5s6duyoJUuW5NuvX79+VusWL16sJ554okjH809ZWVnKyMiwWlA0V65cUc+ePWU2m7VgwYLSLgcAAAC4bQjvKLTg4GAdP37c8jo2NlbOzs6yt7dX9+7d5eHhYZmVvxk//fSTAgMDZWf3fxeCzJw5U87OzpYlPT3daptKlSpp2LBhevHFF60u5f+7I0eO6JtvvlGvXr0kSX369NG7776bZyZfkiIiIpSRkaHt27fr4sWLev/999WvX798xz148KBVbc7OznrmmWcKPL74+Hi5ublZln/O/P+beHl5ydbWVmlpaVbtaWlpBV6t4OPjU6j+ucH9119/1aZNm5h1BwAAwF2F8I5CM5vNVrPgo0aN0v79+7V161Y1bdpUr7/+uqpVq1Ys++rXr5/279+vN998UxcvXsw3cMfGxur3338v8F72xYsXKzw8XF5eXpKkhx56SOnp6dq6dWuevmXKlLGE+9WrV6tGjRqqV69evuMGBQVp//79VsukSZMKPJYxY8YoPT3dspw4caIwb8EdqWzZsmrUqJG2bNliacvJydGWLVvUrFmzfLdp1qyZVX9J2rRpk1X/3OB+5MgRbd68WeXLly+ZAwAAAAAMinveUWiHDh1SlSpVLK+9vLxUrVo1VatWTatXr1bdunUVGhqqWrVqSZJcXV118eJF5eTkyMbm/z4nOnfunKRrTxGXpOrVq+vLL7/UlStXVKZMGUmSu7u73N3d8zxE7u/c3d01ZswYTZw4UREREVbrsrOztXTpUqWmplrN6GdnZ2vx4sV68MEH84zXr18/NW3aVN9//32Bs+7StYB6Mx9S2Nvby97evtD973QxMTGKjIxUaGiomjRpolmzZunixYuKjo6WJPXt21d+fn6Kj4+XJA0bNkytWrXSjBkz9PDDD+u9997T7t279dZbb0m6Fty7d++uvXv3av369crOzrbcD+/p6VkstzYAAAAARsfMOwpl69atOnjwoLp165bven9/f/Xq1cvqyfBBQUG6evWq9u/fb9V37969kqQaNWpIknr37q0LFy5o/vz5N13XkCFDZGNjo9mzZ1u1b9iwQefPn9e+ffusZshXrlyptWvXWj5A+LvatWurdu3a+v777/X444/fdC24plevXpo+fbri4uJUv3597d+/XwkJCZaH0iUnJyslJcXSv3nz5lqxYoXeeusthYSEaM2aNVq3bp3q1KkjSTp58qQ+/vhj/fbbb6pfv758fX0ty9dff10qxwgAAADcbsy8I4+srCylpqYqOztbaWlpSkhIUHx8vCIiItS3b98Ctxs2bJjq1Kmj3bt3KzQ0VLVr11b79u3Vr18/zZgxQ4GBgUpKStLw4cPVq1cv+fn5Sbp22fTzzz+v559/Xr/++qseffRR+fv7KyUlRYsWLZLJZLKauf87BwcHTZw4UYMGDbJqX7RokR5++GGFhIRYtdeqVUsjRozQ8uXL82wjXfuQ4sqVK9f9CrKrV6/meRK6yWTK88T0u9ngwYM1ePDgfNclJibmaevRo4d69OiRb/+AgIB8b5sAAAAA7ibMvCOPhIQE+fr6KiAgQB06dNC2bds0Z84cffTRR7K1tS1wu1q1aql9+/aKi4uztK1atUqtWrXS008/rdq1a2vo0KHq3Lmz3nnnHattp0+frhUrVmjfvn2KiIhQ9erV1aNHD+Xk5GjHjh3XfThZZGSkAgMDLa/T0tL06aef5nuVgI2Njbp27apFixblO5aTk9MNvzv8hx9+sJr99fX1VeXKla+7DQAAAADcCpOZKS3gtsrIyJCbm5vGbz8qB2eX0i6nWI1u4FXaJQAAAAB3jNxskJ6efsNvU2LmHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDBEd4BAAAAADA4wjsAAAAAAAZHeAcAAAAAwOAI7wAAAAAAGBzhHQAAAAAAgyO8AwAAAABgcIR3AAAAAAAMjvAOAAAAAIDB2ZV2AcDdKiakvFxdXUu7DAAAAAB3AGbeAQAAAAAwOMI7AAAAAAAGR3gHAAAAAMDgCO8AAAAAABgc4R0AAAAAAIMjvAMAAAAAYHCEdwAAAAAADI7wDgAAAACAwRHeAQAAAAAwOMI7AAAAAAAGR3gHAAAAAMDgCO8AAAAAABgc4R0AAAAAAIMjvAMAAAAAYHCEdwAAAAAADI7wDgAAAACAwRHeAQAAAAAwOMI7AAAAAAAGR3gHAAAAAMDg7Eq7AOBuYzabJUkZGRmlXAkAAACA0pSbCXIzwvUQ3oHb7MyZM5Ikf3//Uq4EAAAAgBGcP39ebm5u1+1DeAduM09PT0lScnLyDf8DBQqSkZEhf39/nThxQq6urqVdDu5AnEO4VZxDuFWcQygOd/p5ZDabdf78eVWqVOmGfQnvwG1mY3PtURNubm535D8wMBZXV1fOI9wSziHcKs4h3CrOIRSHO/k8KuyEHg+sAwAAAADA4AjvAAAAAAAYHOEduM3s7e01fvx42dvbl3YpuINxHuFWcQ7hVnEO4VZxDqE43E3nkclcmGfSAwAAAACAUsPMOwAAAAAABkd4BwAAAADA4AjvAAAAAAAYHOEdAAAAAACDI7wDxWDevHkKCAiQg4ODmjZtql27dl23/+rVqxUcHCwHBwfVrVtXGzZssFpvNpsVFxcnX19flStXTmFhYTpy5EhJHgJKWXGfQ1FRUTKZTFZLhw4dSvIQUMpu5hz64Ycf1K1bNwUEBMhkMmnWrFm3PCb+HYr7PJowYUKef4uCg4NL8AhQ2m7mHHr77bf1wAMPyMPDQx4eHgoLC8vTn7+J7j7FfQ79m/4mIrwDt2jVqlWKiYnR+PHjtXfvXoWEhCg8PFynT5/Ot//XX3+t3r1766mnntK+ffvUpUsXdenSRd9//72lz7Rp0zRnzhwtXLhQO3fulJOTk8LDw3Xp0qXbdVi4jUriHJKkDh06KCUlxbKsXLnydhwOSsHNnkOZmZkKDAzU1KlT5ePjUyxj4s5XEueRJNWuXdvq36Ivv/yypA4Bpexmz6HExET17t1b27Zt044dO+Tv76/27dvr5MmTlj78TXR3KYlzSPoX/U1kBnBLmjRpYh40aJDldXZ2trlSpUrm+Pj4fPv37NnT/PDDD1u1NW3a1Pz000+bzWazOScnx+zj42N+7bXXLOvPnTtntre3N69cubIEjgClrbjPIbPZbI6MjDR37ty5ROqF8dzsOfR3lStXNr/++uvFOibuTCVxHo0fP94cEhJSjFXCyG71342rV6+aXVxczEuXLjWbzfxNdDcq7nPIbP53/U3EzDtwCy5fvqw9e/YoLCzM0mZjY6OwsDDt2LEj32127Nhh1V+SwsPDLf2PHTum1NRUqz5ubm5q2rRpgWPizlUS51CuxMREVaxYUUFBQXr22Wd15syZ4j8AlLqinEOlMSaMrSR/50eOHFGlSpUUGBioJ554QsnJybdaLgyoOM6hzMxMXblyRZ6enpL4m+huUxLnUK5/y99EhHfgFvzxxx/Kzs6Wt7e3Vbu3t7dSU1Pz3SY1NfW6/XP/92bGxJ2rJM4h6drlYcuWLdOWLVv06quv6vPPP1fHjh2VnZ1d/AeBUlWUc6g0xoSxldTvvGnTplqyZIkSEhK0YMECHTt2TA888IDOnz9/qyXDYIrjHIqNjVWlSpUs4Y2/ie4uJXEOSf+uv4nsSrsAAEDxe+yxxyw/161bV/Xq1VPVqlWVmJioBx98sBQrA3A36dixo+XnevXqqWnTpqpcubLef/99PfXUU6VYGYxm6tSpeu+995SYmCgHB4fSLgd3oILOoX/T30TMvAO3wMvLS7a2tkpLS7NqT0tLK/DhPT4+Ptftn/u/NzMm7lwlcQ7lJzAwUF5eXvr5559vvWgYSlHOodIYE8Z2u37n7u7uqlGjBv8W/Qvdyjk0ffp0TZ06VZ999pnq1atnaedvortLSZxD+bmT/yYivAO3oGzZsmrUqJG2bNliacvJydGWLVvUrFmzfLdp1qyZVX9J2rRpk6V/lSpV5OPjY9UnIyNDO3fuLHBM3LlK4hzKz2+//aYzZ87I19e3eAqHYRTlHCqNMWFst+t3fuHCBf3yyy/8W/QvVNRzaNq0aZo8ebISEhIUGhpqtY6/ie4uJXEO5eeO/puotJ+YB9zp3nvvPbO9vb15yZIl5h9//NE8cOBAs7u7uzk1NdVsNpvNTz75pHn06NGW/l999ZXZzs7OPH36dPOhQ4fM48ePN5cpU8Z88OBBS5+pU6ea3d3dzR999JH5u+++M3fu3NlcpUoV819//XXbjw8lr7jPofPnz5tHjhxp3rFjh/nYsWPmzZs3mxs2bGiuXr26+dKlS6VyjChZN3sOZWVlmfft22fet2+f2dfX1zxy5Ejzvn37zEeOHCn0mPj3KYnz6PnnnzcnJiaajx07Zv7qq6/MYWFhZi8vL/Pp06dv+/Gh5N3sOTR16lRz2bJlzWvWrDGnpKRYlvPnz1v14W+iu0dxn0P/tr+JCO9AMXjjjTfM9957r7ls2bLmJk2amL/55hvLulatWpkjIyOt+r///vvmGjVqmMuWLWuuXbu2+dNPP7Van5OTYx43bpzZ29vbbG9vb37wwQfNSUlJt+NQUEqK8xzKzMw0t2/f3lyhQgVzmTJlzJUrVzYPGDCA0PUv9//au/+Yqqs/juOvDxhcuINLApKWggUZJbBQSyi6WjMdw2nNxOkQzGrZUlpJ5RISCa0WRuosBw2Yo6mtn9ZszYgt72Sav0qjH5qu1m65jKVXVsD1fP9ofr5dQb5SBLevz8f22e7n3PN58z5nnz9433PP5/blHjp27JiR1O1wu90XHRP/n/r7PsrPzzfDhw83YWFh5sorrzT5+fnmyJEjAzgiDLS+3EOJiYk93kNPP/203Yf/iS49/XkP/b/9T2QZY8zArvUDAAAAAIC+YM87AAAAAABBjuIdAAAAAIAgR/EOAAAAAECQo3gHAAAAACDIUbwDAAAAABDkKN4BAAAAAAhyFO8AAAAAAAQ5incAAAAAAIIcxTsAAAAAAEGO4h0AAAyYoqIiWZbV7Thy5Ei/xK+vr1dMTEy/xPqrioqKNHPmzEHNoTfHjx+XZVk6cODAYKcCAOiDIYOdAAAAuLRMmzZNdXV1AW3x8fGDlM2FdXZ26rLLLhvsNPpVR0fHYKcAAPiLWHkHAAADKjw8XFdccUXAERoaKkl65513lJmZKYfDoauvvlrl5eXq6uqyr12zZo3S0tLkdDo1cuRIPfTQQ/L5fJKk5uZmLViwQL/++qu9or9ixQpJkmVZevvttwPyiImJUX19vaT/rkZv2bJFbrdbDodDjY2NkqTa2lqlpqbK4XDouuuu04YNG/o03kmTJmnx4sV65JFHdPnllyshIUE1NTU6c+aMFixYoKioKCUnJ2v79u32Nc3NzbIsS++//77S09PlcDg0ceJEHTp0KCD2G2+8oRtuuEHh4eFKSkpSVVVVwPtJSUmqqKjQ/PnzFR0drQceeECjR4+WJN14442yLEuTJk2SJO3Zs0dTpkxRXFycXC6X3G639u3bFxDPsizV1tbqrrvuUmRkpFJSUvTuu+8G9Dl8+LDy8vIUHR2tqKgo5eTk6OjRo/b7f3c+AeBSRfEOAACCwieffKL58+eruLhYX3zxhTZu3Kj6+npVVlbafUJCQrR27VodPnxYDQ0Nampq0uOPPy5Jys7OVnV1taKjo+X1euX1erV06dI+5fDkk0+quLhYra2tmjp1qhobG1VWVqbKykq1trZq1apVKi0tVUNDQ5/iNjQ0KC4uTrt379bixYu1aNEi3XPPPcrOzta+fft05513qqCgQO3t7QHXlZSUqKqqSnv27FF8fLymT5+uzs5OSdLevXs1e/ZszZkzR59//rlWrFih0tJS+wOJc1544QVlZGRo//79Ki0t1e7duyVJO3bskNfr1ZtvvilJOn36tAoLC7Vz5061tLQoJSVFubm5On36dEC88vJyzZ49W5999plyc3M1b948/fLLL5KkH374QbfddpvCw8PV1NSkvXv36t5777U/gOmv+QSAS5IBAAAYIIWFhSY0NNQ4nU77mDVrljHGmDvuuMOsWrUqoP+mTZvM8OHDLxjv9ddfN7GxsfZ5XV2dcblc3fpJMm+99VZAm8vlMnV1dcYYY44dO2Ykmerq6oA+11xzjXnttdcC2ioqKkxWVlavY5wxY4Z97na7za233mqfd3V1GafTaQoKCuw2r9drJJldu3YZY4z5+OOPjSSzefNmu8/JkydNRESE2bJlizHGmLlz55opU6YE/O2SkhJz/fXX2+eJiYlm5syZAX3OjXX//v0XHIMxxvj9fhMVFWW2bdtmt0kyy5cvt899Pp+RZLZv326MMWbZsmVm9OjRpqOjo8eYf2U+AQB/YM87AAAYUJMnT9bLL79snzudTknSwYMH5fF4Alba/X6/fvvtN7W3tysyMlI7duzQ6tWr9eWXX+rUqVPq6uoKeP/vGj9+vP36zJkzOnr0qBYuXKj777/fbu/q6pLL5epT3PT0dPt1aGioYmNjlZaWZrclJCRIkk6cOBFwXVZWlv166NChGjNmjFpbWyVJra2tmjFjRkD/W265RdXV1fL7/fZWhD+PqTc//fSTli9frubmZp04cUJ+v1/t7e367rvvLjgWp9Op6OhoO+8DBw4oJyenx2cF9Od8AsCliOIdAAAMKKfTqeTk5G7tPp9P5eXluvvuu7u953A4dPz4ceXl5WnRokWqrKzU0KFDtXPnTi1cuFAdHR29Fu+WZckYE9B27uvn5+f253wkqaamRjfffHNAv3OF8cU6v5i1LCugzbIsSdLZs2f7FPdi/HlMvSksLNTJkyf10ksvKTExUeHh4crKyur2kLuexnIu74iIiAvG78/5BIBLEcU7AAAICpmZmfrqq696LOylP/Z4nz17VlVVVQoJ+eOxPVu3bg3oExYWJr/f3+3a+Ph4eb1e+/ybb77ptr/8fAkJCRoxYoS+/fZbzZs3r6/D6RctLS0aNWqUJKmtrU1ff/21UlNTJUmpqanyeDwB/T0ej6699tpei+GwsDBJ6jZPHo9HGzZsUG5uriTp+++/188//9ynfNPT09XQ0NDjk/qDYT4B4N+M4h0AAASFsrIy5eXladSoUZo1a5ZCQkJ08OBBHTp0SM8884ySk5PV2dmpdevWafr06fJ4PHrllVcCYiQlJcnn8+mjjz5SRkaGIiMjFRkZqdtvv13r169XVlaW/H6/nnjiiYv6Gbjy8nItWbJELpdL06ZN0++//65PP/1UbW1tevTRR/+pqbCtXLlSsbGxSkhI0FNPPaW4uDj7N+Qfe+wxTZgwQRUVFcrPz9euXbu0fv36//n09mHDhikiIkIffPCBrrrqKjkcDrlcLqWkpGjTpk0aP368Tp06pZKSkl5X0nvy8MMPa926dZozZ46WLVsml8ullpYW3XTTTRozZsygzycA/JvxtHkAABAUpk6dqvfee08ffvihJkyYoIkTJ+rFF19UYmKiJCkjI0Nr1qzRc889p7Fjx6qxsVGrV68OiJGdna0HH3xQ+fn5io+P1/PPPy9Jqqqq0siRI5WTk6O5c+dq6dKlF7VH/r777lNtba3q6uqUlpYmt9ut+vp6++fW/mnPPvusiouLNW7cOP3444/atm2bvXKemZmprVu3avPmzRo7dqzKysq0cuVKFRUV9RpzyJAhWrt2rTZu3KgRI0bY++ZfffVVtbW1KTMzUwUFBVqyZImGDRvWp3xjY2PV1NQkn88nt9utcePGqaamxv6gZLDnEwD+zSxz/gYwAAAADKrm5mZNnjxZbW1tiomJGex0AABBgJV3AAAAAACCHMU7AAAAAABBjq/NAwAAAAAQ5Fh5BwAAAAAgyFG8AwAAAAAQ5CjeAQAAAAAIchTvAAAAAAAEOYp3AAAAAACCHMU7AAAAAABBjuIdAAAAAIAgR/EOAAAAAECQ+w9z6G6nhWrH/wAAAABJRU5ErkJggg=="},"metadata":{}}]},{"cell_type":"markdown","source":"# Based on feature importances","metadata":{}},{"cell_type":"code","source":"# When == X # 0.9651496076590609\n# highly_corr_features = ['Disease', 'GENENAME', 'SEQUENCE', 'ID', 'DRUGTYPE', 'Drug_high_status'] #5th 0.9672110568929874\nhighly_corr_features = ['Disease', 'GENENAME', 'SEQUENCE', 'ID', 'DRUGTYPE'] #5th 0.9676325415789722\n# highly_corr_features = ['Disease', 'GENENAME', 'SEQUENCE', 'ID'] #5th 0.9675450548138979\n# highly_corr_features = ['Disease', 'GENENAME', 'SEQUENCE'] #5th 0.9563599195530632\n\nX_highly_dropped = X[highly_corr_features]\ny_highly_dropped = y\n\nX_train, X_test, y_train, y_test = train_test_split(X_highly_dropped, y_highly_dropped,\n                                                    stratify=y_highly_dropped, shuffle=True,\n                                                    random_state=42)\n\nparams = {'max_depth': 18, 'learning_rate': 0.02554741000702669, 'n_estimators': 418, \n          'subsample': 0.9899632082718985, 'colsample_bytree': 0.8226626583591214, \n          'gamma': 0.9701683008405076, 'min_child_weight': 3}\n\nmodel = xgb.XGBClassifier(**params)\nmodel.fit(X_train, y_train)\n\npred = model.predict(X_test)\nf1_score(y_test, pred, average='weighted')","metadata":{"execution":{"iopub.status.busy":"2024-09-27T03:33:57.949521Z","iopub.execute_input":"2024-09-27T03:33:57.950453Z","iopub.status.idle":"2024-09-27T03:37:08.178460Z","shell.execute_reply.started":"2024-09-27T03:33:57.950401Z","shell.execute_reply":"2024-09-27T03:37:08.177156Z"},"trusted":true},"execution_count":49,"outputs":[{"execution_count":49,"output_type":"execute_result","data":{"text/plain":"0.9676325415789722"},"metadata":{}}]},{"cell_type":"code","source":"import xgboost as xgb\n\nparams = {'max_depth': 18, 'learning_rate': 0.02554741000702669, 'n_estimators': 418, \n          'subsample': 0.9899632082718985, 'colsample_bytree': 0.8226626583591214, \n          'gamma': 0.9701683008405076, 'min_child_weight': 3}\n\nmodel = xgb.XGBClassifier(**params)\n\nmodel.fit(X, y)\n\npreds = model.predict(test)","metadata":{"execution":{"iopub.status.busy":"2024-09-27T03:38:06.354722Z","iopub.execute_input":"2024-09-27T03:38:06.355244Z","iopub.status.idle":"2024-09-27T03:43:28.173221Z","shell.execute_reply.started":"2024-09-27T03:38:06.355203Z","shell.execute_reply":"2024-09-27T03:43:28.171756Z"},"trusted":true},"execution_count":50,"outputs":[]},{"cell_type":"code","source":"sub['Prediction'] = preds\nsub['Prediction'] = sub['Prediction'].map(category_to_label)\nsub.to_csv('XGB_5thiter.csv', index=False)\nsub.head()    # 0.96742","metadata":{"execution":{"iopub.status.busy":"2024-09-27T03:43:37.345808Z","iopub.execute_input":"2024-09-27T03:43:37.346324Z","iopub.status.idle":"2024-09-27T03:43:37.424289Z","shell.execute_reply.started":"2024-09-27T03:43:37.346256Z","shell.execute_reply":"2024-09-27T03:43:37.422888Z"},"trusted":true},"execution_count":51,"outputs":[{"execution_count":51,"output_type":"execute_result","data":{"text/plain":"       ID Prediction\n0    1076   Approved\n1  190816    Phase 3\n2  180551    Phase 1\n3   51630   Approved\n4   50566  Phase 1/2","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>Prediction</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1076</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>190816</td>\n      <td>Phase 3</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>180551</td>\n      <td>Phase 1</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>51630</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>50566</td>\n      <td>Phase 1/2</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"markdown","source":"----","metadata":{}},{"cell_type":"markdown","source":"# On Full Dataset - without dropping columns","metadata":{}},{"cell_type":"code","source":"import pandas as pd\ndata = pd.read_csv('/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/train.csv')\ndata.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-27T03:22:13.590517Z","iopub.execute_input":"2024-09-27T03:22:13.590951Z","iopub.status.idle":"2024-09-27T03:22:16.566875Z","shell.execute_reply.started":"2024-09-27T03:22:13.590908Z","shell.execute_reply":"2024-09-27T03:22:16.565740Z"},"trusted":true},"execution_count":46,"outputs":[{"execution_count":46,"output_type":"execute_result","data":{"text/plain":"       ID TargetID  DRUGID              DRUGTYPE         Drug_high_status  \\\n0  140736   T51115  D0L4YD  Small molecular drug                 Approved   \n1  133048   T60529  D03NMM  Small molecular drug            Investigative   \n2   60493   T80975  D0T2ER  Small molecular drug                  Phase 1   \n3  169176   T92072  D07ESH  Small molecular drug  Discontinued in Phase 3   \n4  120183   T30082  D0Q0RC  Small molecular drug                 Approved   \n\n        DRUGNAME  PUBCHCID Disease_of_highest_status              Drug_Status  \\\n0    Solifenacin    154059        Overactive bladder                 Approved   \n1         AM-643  46843035    Dermatological disease            Investigative   \n2        TAK-593  24767976       Solid tumour/cancer                  Phase 1   \n3     PF-1913539    176408         Alzheimer disease  Discontinued in Phase 3   \n4  Ethopropazine      3290         Parkinson disease                 Approved   \n\n      UNIPROID                                           TARGNAME GENENAME  \\\n0  CAC1C_HUMAN  Voltage-gated calcium channel alpha Cav1.2 (CA...  CACNA1C   \n1   PGH1_HUMAN               Prostaglandin G/H synthase 1 (COX-1)    PTGS1   \n2  VGFR2_HUMAN  Vascular endothelial growth factor receptor 2 ...      KDR   \n3   AA1R_HUMAN                     Adenosine A1 receptor (ADORA1)   ADORA1   \n4   ACES_HUMAN                        Acetylcholinesterase (AChE)     ACHE   \n\n                                            SYNONYMS  \\\n0  Voltage-gated calcium channel subunit alpha Ca...   \n1  Prostaglandin-endoperoxide synthase 1; Prostag...   \n2  VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyro...   \n3     Adenosine receptor A1; A(1) adenosine receptor   \n4                                 YT; N-ACHE; ARACHE   \n\n                                            FUNCTION  \\\n0  Mediates influx of calcium ions into the cytop...   \n1  Converts arachidonate to prostaglandin H2 (PGH...   \n2  Plays an essential role in the regulation of a...   \n3  The activity of this receptor is mediated by G...   \n4  Role in neuronal apoptosis. Terminates signal ...   \n\n                             BIOCLASS  \\\n0           Voltage-gated ion channel   \n1  Paired donor oxygen oxidoreductase   \n2                              Kinase   \n3                      GPCR rhodopsin   \n4          Carboxylic ester hydrolase   \n\n                                            SEQUENCE  \\\n0  MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...   \n1  MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...   \n2  MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...   \n3  MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...   \n4  MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...   \n\n                               Disease Accession Number Target_Status  \n0           Genetic cardiac arrhythmia           Q13936    Terminated  \n1                 Rheumatoid arthritis           P23219      Approved  \n2                 Renal cell carcinoma           P35968      Approved  \n3               Hyper-lipoproteinaemia           P30542       Phase 2  \n4  Oesophageal/gastroduodenal disorder           P22303      Approved  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ID</th>\n      <th>TargetID</th>\n      <th>DRUGID</th>\n      <th>DRUGTYPE</th>\n      <th>Drug_high_status</th>\n      <th>DRUGNAME</th>\n      <th>PUBCHCID</th>\n      <th>Disease_of_highest_status</th>\n      <th>Drug_Status</th>\n      <th>UNIPROID</th>\n      <th>TARGNAME</th>\n      <th>GENENAME</th>\n      <th>SYNONYMS</th>\n      <th>FUNCTION</th>\n      <th>BIOCLASS</th>\n      <th>SEQUENCE</th>\n      <th>Disease</th>\n      <th>Accession Number</th>\n      <th>Target_Status</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>140736</td>\n      <td>T51115</td>\n      <td>D0L4YD</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Solifenacin</td>\n      <td>154059</td>\n      <td>Overactive bladder</td>\n      <td>Approved</td>\n      <td>CAC1C_HUMAN</td>\n      <td>Voltage-gated calcium channel alpha Cav1.2 (CA...</td>\n      <td>CACNA1C</td>\n      <td>Voltage-gated calcium channel subunit alpha Ca...</td>\n      <td>Mediates influx of calcium ions into the cytop...</td>\n      <td>Voltage-gated ion channel</td>\n      <td>MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...</td>\n      <td>Genetic cardiac arrhythmia</td>\n      <td>Q13936</td>\n      <td>Terminated</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>133048</td>\n      <td>T60529</td>\n      <td>D03NMM</td>\n      <td>Small molecular drug</td>\n      <td>Investigative</td>\n      <td>AM-643</td>\n      <td>46843035</td>\n      <td>Dermatological disease</td>\n      <td>Investigative</td>\n      <td>PGH1_HUMAN</td>\n      <td>Prostaglandin G/H synthase 1 (COX-1)</td>\n      <td>PTGS1</td>\n      <td>Prostaglandin-endoperoxide synthase 1; Prostag...</td>\n      <td>Converts arachidonate to prostaglandin H2 (PGH...</td>\n      <td>Paired donor oxygen oxidoreductase</td>\n      <td>MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...</td>\n      <td>Rheumatoid arthritis</td>\n      <td>P23219</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>60493</td>\n      <td>T80975</td>\n      <td>D0T2ER</td>\n      <td>Small molecular drug</td>\n      <td>Phase 1</td>\n      <td>TAK-593</td>\n      <td>24767976</td>\n      <td>Solid tumour/cancer</td>\n      <td>Phase 1</td>\n      <td>VGFR2_HUMAN</td>\n      <td>Vascular endothelial growth factor receptor 2 ...</td>\n      <td>KDR</td>\n      <td>VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyro...</td>\n      <td>Plays an essential role in the regulation of a...</td>\n      <td>Kinase</td>\n      <td>MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...</td>\n      <td>Renal cell carcinoma</td>\n      <td>P35968</td>\n      <td>Approved</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>169176</td>\n      <td>T92072</td>\n      <td>D07ESH</td>\n      <td>Small molecular drug</td>\n      <td>Discontinued in Phase 3</td>\n      <td>PF-1913539</td>\n      <td>176408</td>\n      <td>Alzheimer disease</td>\n      <td>Discontinued in Phase 3</td>\n      <td>AA1R_HUMAN</td>\n      <td>Adenosine A1 receptor (ADORA1)</td>\n      <td>ADORA1</td>\n      <td>Adenosine receptor A1; A(1) adenosine receptor</td>\n      <td>The activity of this receptor is mediated by G...</td>\n      <td>GPCR rhodopsin</td>\n      <td>MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...</td>\n      <td>Hyper-lipoproteinaemia</td>\n      <td>P30542</td>\n      <td>Phase 2</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>120183</td>\n      <td>T30082</td>\n      <td>D0Q0RC</td>\n      <td>Small molecular drug</td>\n      <td>Approved</td>\n      <td>Ethopropazine</td>\n      <td>3290</td>\n      <td>Parkinson disease</td>\n      <td>Approved</td>\n      <td>ACES_HUMAN</td>\n      <td>Acetylcholinesterase (AChE)</td>\n      <td>ACHE</td>\n      <td>YT; N-ACHE; ARACHE</td>\n      <td>Role in neuronal apoptosis. Terminates signal ...</td>\n      <td>Carboxylic ester hydrolase</td>\n      <td>MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...</td>\n      <td>Oesophageal/gastroduodenal disorder</td>\n      <td>P22303</td>\n      <td>Approved</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"from sklearn.model_selection import train_test_split\nX_train, X_val, y_train, y_val = train_test_split(data.drop('Target_Status', axis=1),\n                                                  data['Target_Status'], random_state=42,\n                                                  stratify=data['Target_Status'], shuffle=True)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:11:08.155960Z","iopub.execute_input":"2024-09-26T20:11:08.156348Z","iopub.status.idle":"2024-09-26T20:11:08.587930Z","shell.execute_reply.started":"2024-09-26T20:11:08.156302Z","shell.execute_reply":"2024-09-26T20:11:08.586503Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"data.columns","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:12:00.212678Z","iopub.execute_input":"2024-09-26T20:12:00.214043Z","iopub.status.idle":"2024-09-26T20:12:00.223465Z","shell.execute_reply.started":"2024-09-26T20:12:00.213983Z","shell.execute_reply":"2024-09-26T20:12:00.221856Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"le_cols = ['TargetID', 'DRUGID', 'DRUGTYPE', 'Drug_high_status', 'DRUGNAME',\n       'PUBCHCID', 'Disease_of_highest_status', 'Drug_Status', 'UNIPROID',\n       'TARGNAME', 'GENENAME', 'SYNONYMS', 'FUNCTION', 'BIOCLASS', 'SEQUENCE',\n       'Disease', 'Accession Number']\n\nfrom sklearn.preprocessing import LabelEncoder\nfor i in le_cols:\n    le = LabelEncoder()\n    X_train[i] = le.fit_transform(X_train[i])\n    X_val[i] = X_val[i].apply(lambda x: le.transform([x])[0] if x in le.classes_ else -1 if pd.notna(x) else -1)\n# X_test[col] = X_test[col].apply(lambda x: label_encoder.transform([x])[0] if x in label_encoder.classes_ else -1 if pd.notna(x) else -1)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:13:26.872061Z","iopub.execute_input":"2024-09-26T20:13:26.872601Z","iopub.status.idle":"2024-09-26T20:21:08.623145Z","shell.execute_reply.started":"2024-09-26T20:13:26.872557Z","shell.execute_reply":"2024-09-26T20:21:08.621788Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"le = LabelEncoder()\ny_train = le.fit_transform(y_train)\n# y_val = le.transform(y_val)\ny_val = y_val.apply(lambda x: le.transform([x])[0] if x in le.classes_ else -1 if pd.notna(x) else -1)\nprint(le.classes_)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:21:08.625896Z","iopub.execute_input":"2024-09-26T20:21:08.626426Z","iopub.status.idle":"2024-09-26T20:21:12.051527Z","shell.execute_reply.started":"2024-09-26T20:21:08.626371Z","shell.execute_reply":"2024-09-26T20:21:12.050286Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"from xgboost import XGBClassifier\nparam = {'max_depth': 10, 'learning_rate': 0.09887667319531757, 'n_estimators': 286,\n         'subsample': 0.8818473315577697, 'colsample_bytree': 0.7911835582470869, \n         'gamma': 0.5882283567417588, 'min_child_weight': 1} # nothing dropped (3rd submission)\nmodel = XGBClassifier(**param)\nmodel.fit(X_train, y_train, verbose=2)\n\npreds = model.predict(X_val)\n\nfrom sklearn.metrics import f1_score, accuracy_score","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:45:10.386977Z","iopub.execute_input":"2024-09-26T20:45:10.387465Z","iopub.status.idle":"2024-09-26T20:46:21.075829Z","shell.execute_reply.started":"2024-09-26T20:45:10.387420Z","shell.execute_reply":"2024-09-26T20:46:21.074721Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"accuracy_score(y_val, preds)\n","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:23:39.663588Z","iopub.execute_input":"2024-09-26T20:23:39.664745Z","iopub.status.idle":"2024-09-26T20:23:39.677395Z","shell.execute_reply.started":"2024-09-26T20:23:39.664693Z","shell.execute_reply":"2024-09-26T20:23:39.675958Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"f1_score(y_val, preds, average='weighted')","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:23:41.854021Z","iopub.execute_input":"2024-09-26T20:23:41.854527Z","iopub.status.idle":"2024-09-26T20:23:41.886521Z","shell.execute_reply.started":"2024-09-26T20:23:41.854482Z","shell.execute_reply":"2024-09-26T20:23:41.884995Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"print('Done')","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:23:06.479756Z","iopub.status.idle":"2024-09-26T20:23:06.480211Z","shell.execute_reply.started":"2024-09-26T20:23:06.479986Z","shell.execute_reply":"2024-09-26T20:23:06.480013Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"test = pd.read_csv('/kaggle/input/nexus-by-djs-nsdc-ultraceuticals/test.csv')\ntest.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:27:04.043100Z","iopub.execute_input":"2024-09-26T20:27:04.043684Z","iopub.status.idle":"2024-09-26T20:27:06.616593Z","shell.execute_reply.started":"2024-09-26T20:27:04.043623Z","shell.execute_reply":"2024-09-26T20:27:06.615341Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"le_cols = ['TargetID', 'DRUGID', 'DRUGTYPE', 'Drug_high_status', 'DRUGNAME',\n       'PUBCHCID', 'Disease_of_highest_status', 'Drug_Status', 'UNIPROID',\n       'TARGNAME', 'GENENAME', 'SYNONYMS', 'FUNCTION', 'BIOCLASS', 'SEQUENCE',\n       'Disease', 'Accession Number']\n\nfrom sklearn.preprocessing import LabelEncoder\nfor i in le_cols:\n    le = LabelEncoder()\n    data[i] = le.fit_transform(data[i])\n    test[i] = test[i].apply(lambda x: le.transform([x])[0] if x in le.classes_ else -1 if pd.notna(x) else -1)\n# X_test[col] = X_test[col].apply(lambda x: label_encoder.transform([x])[0] if x in label_encoder.classes_ else -1 if pd.notna(x) else -1)\nprint(\"Done\")","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:27:48.108788Z","iopub.execute_input":"2024-09-26T20:27:48.109298Z","iopub.status.idle":"2024-09-26T20:41:05.869378Z","shell.execute_reply.started":"2024-09-26T20:27:48.109253Z","shell.execute_reply":"2024-09-26T20:41:05.867744Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"preds = model.predict(test)","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:41:05.872310Z","iopub.execute_input":"2024-09-26T20:41:05.872885Z","iopub.status.idle":"2024-09-26T20:41:09.540424Z","shell.execute_reply.started":"2024-09-26T20:41:05.872831Z","shell.execute_reply":"2024-09-26T20:41:09.539339Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"# Define the list of categories in the order you want to encode them\ncategories = [\n    'Application submitted', 'Approved', 'Approved (orphan drug)', 'BLA submitted', 'Clinical trial',\n    'Discontinued in Phase 1', 'Discontinued in Phase 1/2', 'Discontinued in Phase 2', 'Discontinued in Phase 2/3',\n    'Discontinued in Phase 2b', 'Discontinued in Phase 3', 'Discontinued in Phase 4',\n    'Discontinued in Preregistration', 'IND submitted', 'Investigative', 'Patented', 'Phase 0', 'Phase 1', 'Phase 1/2',\n    'Phase 1/2a', 'Phase 1b', 'Phase 1b/2a', 'Phase 2', 'Phase 2/3', 'Phase 2a', 'Phase 2b', 'Phase 3', 'Phase 4',\n    'Preclinical', 'Preregistration', 'Registered', 'Terminated', 'Withdrawn from market'\n]\n\n# Create a dictionary mapping each category to its corresponding label (0, 1, 2, etc.)\ncategory_to_label = {idx : category for idx, category in enumerate(categories)}\n\n# Function to apply the mapping\n# def map_to_label(value):\n#     return category_to_label.get(value, 1)  # Returns 1 if the value is not found in the dictionary\ncategory_to_label","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:41:09.542200Z","iopub.execute_input":"2024-09-26T20:41:09.543360Z","iopub.status.idle":"2024-09-26T20:41:09.556159Z","shell.execute_reply.started":"2024-09-26T20:41:09.543296Z","shell.execute_reply":"2024-09-26T20:41:09.554834Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"sub = pd.DataFrame(test['ID'])\nsub['Prediction'] = preds\nsub.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:41:09.558949Z","iopub.execute_input":"2024-09-26T20:41:09.559382Z","iopub.status.idle":"2024-09-26T20:41:09.583354Z","shell.execute_reply.started":"2024-09-26T20:41:09.559323Z","shell.execute_reply":"2024-09-26T20:41:09.581868Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"sub['Prediction'] = sub['Prediction'].map(category_to_label)\nsub.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:41:09.585053Z","iopub.execute_input":"2024-09-26T20:41:09.585451Z","iopub.status.idle":"2024-09-26T20:41:09.607400Z","shell.execute_reply.started":"2024-09-26T20:41:09.585411Z","shell.execute_reply":"2024-09-26T20:41:09.606051Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"sub.to_csv('XGB_on_full_data.csv', index=False)\nsub.head()","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:41:09.608977Z","iopub.execute_input":"2024-09-26T20:41:09.609442Z","iopub.status.idle":"2024-09-26T20:41:09.733445Z","shell.execute_reply.started":"2024-09-26T20:41:09.609399Z","shell.execute_reply":"2024-09-26T20:41:09.731622Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"print('Done!')","metadata":{"execution":{"iopub.status.busy":"2024-09-26T20:41:09.734991Z","iopub.execute_input":"2024-09-26T20:41:09.735415Z","iopub.status.idle":"2024-09-26T20:41:09.741911Z","shell.execute_reply.started":"2024-09-26T20:41:09.735373Z","shell.execute_reply":"2024-09-26T20:41:09.740547Z"},"trusted":true},"execution_count":null,"outputs":[]},{"cell_type":"code","source":"","metadata":{},"execution_count":null,"outputs":[]}]}